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measure of a research
paper is to have the 
report featured on the 
cover of the journal in 
which it is published. 
This should provide 
the first clue that
Confocal microsco^' xfODO, is $Sed by 
the Cardiovascular Research Institute to 
detect dying heart muscle cells (myocytes) 
in the failing heart. The large arrow show, 
a nucleus labeled with a probe specific for 
DNA damage that occurs during necrosis 
(yellow fluorescence). Arrowheads are 
pointing to the disrupted plasma 
membrane, indicated by missing segments 
of vinculin, a protein component of the 
membrane (yellow fluorescence).
Courtesy of Jan Kajstura, Ph.D.
the Cardiovascular Research
Institute at New York Medical
College has hit its stride. In 
the first three months of this
year, all three of its published
(continued on page 10)
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Psychiatrist Michael Blumenfield, M.D., 
focuses on the media, who both suffer from 
and aggravate the syndrome.
Posttraumatic stress disorder (PTSD) is a diagnosis that conjures up images of Vietnam vets using drugs and alcohol to block their linger­ing horrors, or if you’re old enough, the infantrymen in World War I and II 
■who were discharged as “shell-shocked.” A younger generation attuned 
to terrorism probably is more likely to think of the innocent bystanders 
who survive disasters or witness them. Either way, those affected will 
suffer the same debilitating symptoms of anxiety, severe depression, 
intrusive recollections, avoidance, and impaired sleep and sexual function,
(continued on page 12)
The skyline of the Valhalla 
campus has changed as the 
Medical Education Center 
proceeds on schedule for 
completion this spring.
The Class of2004 is slated 
to move in during April to 
finish out the school year.
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Glimpsing
0 Light at the ^ End of the Tunnel
for Spinal
Cord Injury
Joseph D. Etlinger, Ph.D., and Richard J. Zeman, 
Ph.D., can mend spinal cords in rats with 
clenhuterol. Human trials are in the offing.
he neurological lifeline of the human 
body is the spinal cord—^the distribu­
tion network of central nervous system 
tissue joining what the brain composes 
and the body disposes. Running 
aft from the base of the skull to the 
tailbone, it forms an organic informa­
tion superhighway cloaked by the 
infrastructure of the back’s 33 
vertebrae, 31 pairs of nerves, 40 
muscles and abundant connecting 
tendons and ligaments. Still, there 
is a downside to this exquisite 
arrangement: any damage to the spine
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spreads further injury to the spinal 
cord and beyond. Depending on 
where the vertebrae and nerves 
are damaged, a victim may be 
unable to move his muscles 
(which ultimately contract in 
spasms or atrophy from disuse); 
lose all sensation incorporating 
hot and cold, pressure, pain or 
equilibrium; be unable to regulate 
body temperature; and lose 
control of bowel, bladder and 
sexual functions. Such catastroph­
ic injuries strike an estimated 
10,000 individuals in the U.S. each 
year, most of them men between 
the ages of 15 and 33.
What are the odds that a single 
drug could repair a severed spine 
or reverse the damage wrought by 
a spinal cord contusion? If you 
ask two researchers in the
Department of Cell Biology and 
Anatomy at New York Medical 
College, you might hear them 
whisper clenbuterol in reply. As 
basic scientists, Joseph D. Etlinger, 
Ph.D., professor and chair, and 
Richard J. Zeman, Ph.D., assistant 
professor, are reticent investigators 
accustomed to the painfully slow 
pace of research and are indiffer­
ent to probabilities. They have 
been working for more than a 
decade with clenbuterol, a cousin 
to the active ingredient albuterol 
found in broncodilators used by 
asthmatics. (Another relative, 
adrenaline, is the better known 
member of this family of beta- 
adrenergic agonists, an appellation 
denoting their ability to combine 
with cell receptors to initiate 
a reaction.) But there is one 
complication concerning clen­
buterol that must be resolved. It 
has never been licensed for clinical 
use in the U.S.
Slow but sure
Drs. Etlinger and Zeman have 
published seven papers together 
on clenbuterol since 1987, when 
the former left SUNY-Health 
Science Center in Brooklyn to 
head up the Department of Cell 
Biology and Anatomy here. Dr. 
Zeman, who also directs the 
Fluorescence Microscope Imaging 
Facility in the department, 
followed one year later. Fueled by 
Etlinger’s longstanding interest in 
muscle atrophy and degeneration, 
their collaboration on clenbuterol 
began with a paper relating to 
denervation and atrophy. (They 
actually had worked together since 
1981.) Then came a study reveal­
ing clenbuterol’s ability to reduce 
net bone loss in the denervated 
hind limbs of rats. When their fifth 
paper showed how clenbuterol 
was able to reverse the scoliosis 
they had generated in nearly 
severed rat spines, they knew 
they were on to something.
That scoliosis study was published 
in 1997, two years after actor 
Christopher Reeve fractured the 
top vertebrae of his neck during a 
show jumping accident with his 
horse, leaving him paralyzed from 
the neck down and unable to 
breathe. Prompt medical attention 
and surgery saved his physically 
wrecked life, but it was his great 
intellect and the spirit he fashioned 
that turned the scant awareness of 
spinal cord injury into the major 
investigative interest it has 
become. Whether Reeve would 
be able to benefit from clenbuterol 
is not something that has been 
addressed since Drs. Etlinger and 
Zeman have used only just-injured 
animal subjects in their experi-
When Richard J, Zeman, Ph.D., left, and Joseph D. Etlinger, Ph.D., first used 
clenbuterol in muscular dystrophy-related research, they found the drug could 
reduce degeneration of exercised or aged dystrophic (MDX) muscle. It appears 
that clenbuterol also plays a role in regenerating the injured spinal cord. The 
poster presentation behind the researchers was displayed at the San Diego meet­
ing of the Federation of American Societies for Experimental Biology in April.
These dorsoventral radiograms of rats demonstrate scoliosis four weeks after their spinal cords were transected three-quarters 
through. From left, panel one shows thoracic scoliosis after transection at T5; panel three shows luptbar scoliosis after transection 
at Til. Panels 2 and 4 illustrate that the scoliosis was greatly reduced by treatment with clenbuterol. (Courtesy of the Department of 
Cell Biology and Anatomy)
merits. They are skeptical that 
their drug could reverse a long 
lasting injury like Reeve’s, but the 
possibility surely will be looked at 
in studies planned with the' 
Department of Neurosurgery.
Next query
Clenbuterol’s success with an 
animal model of scoliosis earned 
the research duo a patent and the 
conviction to study human disease. 
But first they were faced with a 
larger question: Did the drug 
work by preventing degeneration 
of the spine or by regenerating the 
spine? The resolution can be 
found in “Clenbuterol, a B2- 
Adrenoceptor Agonist, Improves 
Locomotor and Histological 
Outcomes after Spinal Cord 
Contusion in Rats.” Published in 
the top-rated journal Experimental 
Neurology last year, it named 
department colleagues Drs. Yong 
Feng and Hong Peng as additional 
contributors. The big difference in 
this study was their decision to 
cause injury by impact as “most 
injuries are a combination of com­
pression, twisting and impact, such 
as in an auto accident,” says Dr. 
Etlinger. “We used a device based 
on the ‘NYU impactor,’ which was 
developed at NYU in 1911. It’s the 
gold standard for investigating 
these types of injuries.”
Ninety animal subjects were given 
clenbuterol in their drinking water, 
and then measured for return of 
function in their limbs. And by 
later examining their spinal cords 
to see if nerves had been spared, 
researchers were able to correlate 
their findings with actual 
behavioral recovery.
“We concluded in our paper that 
clenbuterol produces a substantial 
recovery of function as well as a 
sparing of tissue—maybe even 
regeneration,” Dr. Etlinger states.
Why clenbuterol?
Dr. Zeman explains, “Clenbuterol 
is known to affect cyclic AMP and 
calcium within the muscles. We 
became interested because we
knew these substances regulate the 
pathways in muscle that lead 
to atrophy and hypertrophy 
(thickening), and clenbuterol 
may provide a neuroprotective 
mechanism via these pathways 
as well.. .To get clenbuterol 
approved as a drug we must go 
through clinical trials. We could 
use albuterol and there are reasons 
to believe it would work just as 
well, but clenbuterol is more 
potent, so we need to interest a 
company in backing these trials.”
With a patent pending for this 
spine-healing process, the doctors 
will further their research through 
their incorporated company 
MotoGen. “We have received 
support from Neurosurgery and 
Radiation Medicine and a grant 
from the NIH, and we’ll lease space 
from the College to carry out our 
work,” says Dr. Etlinger. “Zeman 
will be the PI. Based on our 
animal data, we have the ability to 
design a human clinical study that 
will allow us to look at clenbuterol 
alone or combined with radiation
(continued on page 15)
Ffeux E. WAssERMArffl, Ph.D.
I
f a university is fortunate, there is one professor 
on the faculty who has seen it all, remembers 
everything, and tells it like it is with the audacity and 
self-confidence granted men of a certain age.
New York Medical College is endowed with Felix E. 
Wassermann, Ph.D., whose institutional memory is 
exceeded only by his talents as a scientist, ethicist and 
pundit. At the age of 76, when his contemporaries 
have long since retired, Dr. Wassermann agreed— 
for the second time in his career—to become acting 
chairman of the Department of Microbiology and 
Immunology. “I never wanted to be chairman, either 
time,” he insists. “When you are, you alienate some­
body—even if you just change a doorknob!”
Notwithstanding that assertion, Dr. Wassermann 
accepted the job on April 1, 1999. “I told the dean that 
April Fool’s Day was a very appropriate time for me to 
do this,” he says, cracking the first of many one-liners 
that would do a stand-up comic proud. “I’m too old 
and I’m not aggressive enough. People like me
should be put out to pasture. You have to fight for 
your people and your discipline.. .1 took the job for a 
few reasons. It means I don’t have to take anybody 
else’s nonsense [writer’s discretion]. And since I’m 
obviously not in the running for the permanent posi­
tion, I don’t have to give the impression of pushing 
innovation. I’m just keeping things going until the 
search committee does its job, but it would be nice to 
find someone who is not doing research in cancer or 
immunology. We need to branch out, in fungi and 
parasites, to build a well-rounded micro department.”
Et tu Felix?
Or, perhaps a virologist, like himself, would do. Not 
only is medical science in Dr. Wassermann’s blood, it’s 
in his genes. The Wassermann test for syphilis, which 
in days of yore was essential for getting a marriage 
license, was developed in 1912 by his intern father 
and his father’s famous first cousin. They were both 
physicians doing research at the Kaiser Wilhelm 
Institute in Berlin. Felix Wassermann was born in
8
Germany—in Bamberg, Bavaria—but he lived there 
only for 12 years, until the family fled to Prague ahead 
of the Nazi war machine.
“It seemed like they were coming after us,” he recalls 
of their next move to England, when Germany 
invaded Czechoslovakia in 1939. One year later they 
had made it into Mexico through Acapulco. The final 
leg of their trek ended in early 1941, when they set 
foot in America by way of Cuba. “You had to wait 
three days to enter the U.S. because that was the 
incubation period for trachoma, an eye infection 
caused by Chlamydia trachomatis. It’s transmitted 
by flies,” Dr. Wassermann 
advises, polishing off a 
memory undiminished after 
60 years, with no detail 
too small.
He served in the army of his 
new homeland from 1943 to 
1946 in Europe, rising through 
the ranks to first lieutenant by 
the time he was discharged.
“I was in the military intelli­
gence service interrogating 
prisoners of war. That’s 
why I’m on the Admissions 
Committee now,” he smiles.
“There were no lie detectors.
We just used our brains.”
When the war was over.
Dr. Wassermann used those 
brains to earn bachelor and 
master’s degrees in agricultural 
bacteriology at the University 
of Wisconsin, a curious choice 
of university for a lad who’d 
spent his teens growing up on 
East 70th Street in New York 
City. “My father had a friend 
who taught biochemistry at 
Wisconsin,” he explains, 
suddenly recalling an insult that would never go away. 
“Actually, 1 had already been accepted to MIT and was 
attending the summer session when they withdrew the 
acceptance, apologetically, because I wasn’t a citizen. 
At the time I was Czech.”
Early lesson
During the years before and after he received his 
Ph.D. in microbiology from New York University in 
1958, Dr. Wassermann taught for a living. There was, 
however, one other job he would rather forget. “As 
a bacteriological supervisor in the Methods Research 
Section at Camp Detrick, Maryland, I loaded dried 
anthrax spores into artillery shells for the Army 
Chemical Corps. They were shooting them off to 
see if the spores would survive. Biological warfare 
is a disgusting thing to do. They kept saying it was 
a defensive weapon, but artillery is not a defensive 
weapon—it’s rea/fy offensive.”
When he was hired by the 
Public Health Research 
Institute of the City of New 
York, Dr. Wassermann 
Wbrked in the departments 
of infectious diseases and 
epidemiology, focusing on 
the influenza virus. But he 
“tired of going from lab to 
lab,” and after seven years 
there, found his calling as an 
assistant professor of virology 
in the Department of 
Microbiology at New York 
Medical College, Flower-Eifth 
Avenue Hospitals, in New 
York City. The rest is indeed 
history; he was promoted to 
associate professor in 1967, 
“executive officer” in 1969, 
acting chairman from 1970 
to 1976, and professor in 
1977. He still holds an 
adjunct associate position 
at The Hastings Center, a 
medical ethics think-tank in 
Garrison, N.Y
Ethics credentials
Dr. Wassermann’s passion 
to instill ethics in his medical students resulted, he 
believes, in the first formal ethics program at the 
College. “It was around 1974,1 think, when I 
organized a brown-bag lunch group for people 
interested in talking about problems and aspirations.
(continued on page 14)
I'M JUST KEEPinO THinOS QOiriQ UUTIL 
THE SEARCH COMMITTEE DOES ITS JOB,
BUT IT WOULD BE HICE 
TO FIND SOMEONE WHO IS 
NOT DOING RESEARCH IN 
CANCER OR IMMUNOLOGY.
We need to branch
OUT, IN FUNGI AND 
PARASITES, TO BUILD 
A WELL-ROUNDED 
MICRO DEPARTMENT."
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The Cardiovascular Research Institute team, directed by Piero Anversa, 
M.D., seated, is conducting groundbreaking research in heart failure and 
the role of diabetes in cardiomyopathy. His right hand man, Jan Kajstura, 
Ph.D., assistant professor of medicine, left his native Poland eight years ago 
expressly to join Dr. Anversa’s investigation of coronary heart disease.
The Heart (continued from page 2)
papers received this distinction.
With the seeming regularity of 
a monthly magazine, so much 
landmark data is offered to and 
accepted by elite journals in the 
field that Director Piero Anversa,
M.D., and his team can barely find 
the time to do the grant applica­
tions and research papers that are 
essential to the task. Their scientif­
ic passion is heart failure, the 
number one cause of death and 
hospitalization in people over 65.
Dr. Anversa accounts for his inge­
nuity and their industry this way:
“If you put together 3,000 
cardiologists to get the definition 
of heart failure, you’ll get 3,000 
opinions. Mine is simple: cell 
death. There is no heart failure 
without cell death, and that’s why 
I study cell death and cell growth, 
the two critical cellular events in 
the onset and progression of heart 
failure.. .When you lose more cells 
than you generate, you’re in 
serious trouble.”
Clinical evaluation
If it sounds deceptively simple, 
that is his genius. Colleague John 
A. McClung, M.D. ’75, associate 
professor of medicine and a 
clinical cardiologist, is effusive 
when he talks about Anversa’s 
research—especially its focus on 
the link between diabetes and 
coronary heart disease, the single 
largest killer of males and females 
in America:
“For years there has been 
controversy about the cause of 
diabetic cardiomyopathy. Piero’s 
work is elegant stuff—the first 
clear exposition of cell death and 
high blood sugar—independent of 
heart attack, atherosclerosis and
blood clots.” He is so impressed 
with the findings that he is design­
ing a clinical trial to complement 
Anversa’s investigations. In their 
Vosburgh Pavilion laboratory, 15 
scientists—many from Italy and 
mostly MDs—have established 
that high concentrations of glucose 
caff induce a loss in number and 
hypertrophy (thickening) of 
myocytes (heart muscle cells), 
leading to the cardiomyopathy, 
diastolic dysfunction, loss of heart 
mass and cardiac insufficiency that 
accompany diabetes.
Joins faculty
Dr. Anversa and the university 
began their fruitful association in 
1972, when the Italian born and 
educated physician signed on as 
a visiting assistant professor of 
pathology. Some three decades 
later his reputation extends to the 
appointments he holds at Albert 
Einstein College of Medicine in the 
Bronx, and three institutions in 
Italy in addition to those at the 
College, where he is a professor in
the departments of Pathology, 
Microbiology and Immunology, 
and Medicine. His work has been 
recognized with the Dean’s 
Distinguished Research Award for 
1996, and an appointment as vice 
chairman of the Department of 
Medicine last year. Says William A. 
Frishman, M.D., the chairman who 
appointed him:
“Piero Anversa has made many of 
the seminal discoveries in cardiac 
pathology. His work, and that of 
his colleagues, have provided a 
better understanding of myocardial 
cell death, and the contribution of 
necrosis and apoptosis to cardiac 
pathology. He was one of the first 
to observe that the heart is not a 
terminally differentiated organ and 
that it has the potential to repro­
duce itself—even in old age.”
Dr. Anversa is not only principal 
investigator on five National 
Institutes of Health grants totaling 
$1.9 million, but he also shares 
in an interdepartmental Physiology
Program Project Grant that brings 
another $.3 million to the College 
annually. The nature of his 
research prompts him to use 
mostly human hearts, an expense 
he finds critical to studies that 
involve glycosylation, the addition 
of sugar. “Our animal model is 
a rat, but it does not get type 2 
diabetes, which is the more 
common variety; it does get type 1 
[juvenile diabetes], which is more 
serious.. .1 plan to eventually 
submit a paper that shows our 
studies can be applied to both 
types of diabetes.” The human 
hearts are currently acquired 
from patients having biopsies or 
undergoing transplantation in Italy, 
but they presumably would be 
obtained more easily when heart 
transplant procedures—approved 
but not yet scheduled—commence 
at Westchester Medical Center.
Preceding the focus on diabetes, 
the laboratory’s most important 
papers dealt with myocyte death 
and regeneration, which appeared 
in Proceedings and the journal 
Circulation Research, Dr. Anversa 
says. (As is customary for estab­
lished researchers, his name is 
placed last in both publications.) 
While this quest to heal the heart 
is decidedly basic research, Dr. 
Anversa designs the studies with 
a clinical effect in mind.
Dwarfs cancer
“Heart failure—despite the number 
of drugs on the market—still 
affects a tremendous number of 
people,” Dr. Anversa advises.
“Each year they feel a little better 
and live a little longer, but they still 
die like crazy. We need to devel­
op new strategies to treat cardiac 
problems. For the last several 
years the approach has targeted 
the imbalance between cell growth 
and cell death. If we can prevent
How Diabetes Leads to Heart Failure
he association between diabetes and coronary heart disease is so 
strong that it is often a cardiologist who takes care of a diabetic 
patient. This is why John A. McClung, M.D. ’75, associate professor 
of medicine at the College and chief of critical care cardiology at 
Westchester Medical Center, seldom misses early morning meetings at 
the Cardiovascular Research Institute led by Piero Anversa, M.D. His 
studies showing that high blood sugar kills heart muscle cells have 
motivated Dr. McClung into parallel research that he says has never been 
done in a human model.
“Anversa is looking at a purely cellular event. We are looking at what 
the heart is doing as an organ,” he explains. “Over time, high blood 
sugar kills heart cells. The remaining ventricular muscle cells hypertro­
phy, causing the ventricle to lose its elasticity. These bigger cells require 
more blood flow, making the heart pump harder and harder to feed 
itself. The bigger cells also take up more space as the other heart cells 
are killed off.. .The diastolic dysfunction that results from cell death and 
cell hypertrophy is probably the first sign of heart failure in humans.
In diabetics, unfortunately, it has not been shown to be reversible.”
In the trial Dr. McClung has designed, colleagues will look for signs 
of diastolic dysfunction in the hearts of diabetic patients by echocardio­
gram. Then, to establish whether the subject’s blood sugar is under 
control, they will use a simple hemoglobin AIC blood test to obtain a 
mean glucose reading for the previous two months. The researchers 
are betting that a high AIC level will correlate with poor ventricular 
diastolic function.
“We will treat these patients 
and get their sugar down, 
and half of them will also be 
treated with an ATI receptor 
blocker [losartan]. After six 
months we will repeat their 
echocardiograms. If Piero is 
right, the echoes should be 
just as bad in those patients 
who did not receive the ATI 
blockade, even though their 
sugar is under control, 
because heart cells have died.
We are hoping that diastolic 
function will improve in 
patients who were treated 
with the ATI blocker.
“We can keep a diabetic 
patient’s blood sugar stable,”
Dr. McClung states, “but we 
probably cannot stop the 
damage without controlling 
the mechanism that 
Dr. Anversa has described.”
In its quest to establish whether cardiac failure 
occurs at the cellular level, the Cardiovascular 
Research Institute has gained the clinical 
assistance of cardiologist John A. McClung,
M.D. ’75. Here he is lending a hand with a 
system that measures the force developed by 
a single heart muscle cell. Dr. McClung is 
planning a trial with diabetic patients to clarify 
the role of diabetes in cardiac myopathy 
progressing to heart failure.
(continued on page 15)
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Str6SS Disorder (continued from page 4)
possibly for the remainder of their 
lives. (The criteria to diagnose 
PTSD are conveniently listed in 
section 309.81 of the Diagnostic 
and Statistical Manual IV of Mental 
Disorders, the bible of psychiatry 
commonly known as DSM IV.)
But those in anguish are not the 
only walking wounded. There 
are hidden victims also in distress 
and vulnerable to ending up as 
psychological casualties of natural 
and man-made disasters. Michael 
Blumenfield, M.D., has been a 
vital part of the crusade to identify 
these individuals. “We’re trying 
to make mental health people 
aware that you have to look for 
forgotten victims, to make sure 
they are taken care of. I teach a 
course at the American Psychiatric 
Association (APA) annual meeting 
that deals with the secondary 
victims of disaster. It always fills 
up every year,” he says.
Credentials earned
After nearly a decade of analyzing 
PTSD, Dr. Blumenfield has be­
come a recognized expert who is 
often summoned for consultation 
to the scene of horrifying events. 
His regular day job, however, is 
professor of psychiatry, with sec­
ondary appointments as professor 
of medicine and of surgery, at 
New York Medical College. At 
Westchester Medical Center he is 
director of Consultation Liaison 
Psychiatry in the Department of 
Psychiatry, putting him in charge 
of the seriously ill inpatients who 
display depression and other 
psychological disorders in the 
medical and surgical part of the 
hospital. Once a psychiatric 
consultant for the Burn Unit, he
hidden victims in
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reporters and film editors.
is also director of the clerkship in 
psychiatry for the College.
The hidden victims in Dr. 
Blumenfield’s landscape are not 
the relatives of victims, who may 
also be affected, but secondary 
sufferers who range from emer­
gency medical technicians, police 
and firemen, to school teachers 
(when children are involved), 
funeral home personnel, and in 
particular, the media: newspaper 
and television reporters and 
film editors.
“Sometimes they are inadvertently 
the victims of disaster, or just by 
doing their jobs are themselves 
traumatized. But it’s hard to detect 
their angst because they don’t ask 
for help,” Dr. Blumenfield advises. 
“They will admit their problems 
when confronted, but even then 
they don’t do anything about it. 
The upshot is they may turn to 
drink, or burn out, or take it out 
on their families.” He recom­
mends that anyone qualifying 
as a secondary victim of a major 
trauma have the opportunity to 
be debriefed in a group as soon 
as possible after a tragedy. Then 
there can be follow up with 
psychotherapy and medication if 
needed to alleviate symptoms.
Informing colleagues
Ironically, Dr. Blumenfield also 
happens to be chairman of the 
Joint Commission on Public Affairs 
of the APA, which renders him a 
PR person of sorts. One of his 
colleagues, Robert Ursano, M.D., 
chair of the Department of 
Psychiatry at the Uniformed 
Services University of the Health 
Sciences School of Medicine in 
Bethesda, Md., offers this appraisal 
of his colleague’s quest:
“Dr. Blumenfield has drawn the 
mental health world’s attention to 
both the importance of media after 
disasters and the particular stress 
experienced by reporters. He 
recently organized and chaired an 
outstanding workshop at the APA 
[annual convention in June] that 
was overwhelmingly appreciated 
and applauded by all.” Entitled 
“The Media and Disasters and 
Other Traumatic Events,” the
symposium featured Helen 
Chickering, an NBC-TV reporter in 
Charlotte N.C., and Drs. Ursano 
and Blumenfield.
Chickering continues, “He is 
very well thought of among his 
colleagues in the APA and he was 
a big hit among the broadcast 
journalists at the AMA conference. 
Michael Blumenfield makes us 
think before covering a story.”
Her latter comment alludes 
to his conviction that the media 
should not interview the close 
relatives of disaster victims. 
Zealous TV reporters who exploit 
grief and psychic pain by shoving 
cameras in their faces deserve a 
special slap on the wrist. But 
whether the media is the menace 
or the victim in the disaster, “we 
must not forget about them,” urges 
Dr. Blumenfield. “We must 
approach members of the media 
differently, try to first establish a 
relationship, and then convince 
them that getting help does not 
make them weak or defective.”
Another wrinkle
A close cousin to PTSD is Acute 
Stress Disorder, which takes its toll 
immediately after an event. “In a 
place like New York City,” says Dr. 
Blumenfield, EMS people are 
constantly on the go and exposed 
to traumatic events that are outside 
the realm of human events. The 
human psyche attempts to defend 
against this either by blocking 
them out or playing them over and
over again, in an attempt to master 
the event. Meanwhile, the repeti­
tion interferes with sleeping and 
terrible thoughts intrude during 
the day.”
Dr. Blumenfield’s first paper on 
PSTD was “Development of 
Posttraumatic Stress Disorder” in 
1997. With the assistance of a 
research assistant, he distributed 
detailed questionnaires to 2,051 
New York City EMS employees 
over 28 months (from September 
14, 1990, to January 8, 1993). It 
was a landmark study that evaluat­
ed the potential risk factors for 
developing PTSD.
His penchant for tackling psychi­
atric subjects that are less well
traveled obviously is alive and 
well. The July-August 2000 lead 
article in Psychosomatics featured 
his research report with colleagues 
from the College on “Constant 
Observation in the General 
Hospital.” Not to be confused 
with voyeurism, constant observa­
tion is a technique in which 
continuous monitoring is used to 
assure the safety and well being of 
an individual patient or others.
Whether Dr. Blumenfield’s 
concerns are mainstream or not, 
they ipay inspire at least one of 
the 27 residents in psychiatry who 
spend four months on his service. 
Presumably, the rotation comes 
with very little stress that is likely 
to cause a lasting disorder. ■
"The Media and Disasters and Other Traumatic Events, ” a workshop presented 
at the last American Psychiatric Association annual meeting, was led by Michael 
Blumenfield, M.D., left. The panel included Robert Ursano, M.D., chair of 
psychiatry at the Uniformed Services University of the Health Sciences School 
of Medicine in Bethesda, Md., and Helen Chickering, NBC-TV reporter in 
Charlotte, N.C., who represented the media. (Ellen Daiiager Photo)
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WaSSCrmann (continued from page 9)
It turned out they wanted to talk 
about ethics. We met fairly 
regularly and it developed into a 
formal group for ethics. So I got 
in touch with The Hastings Center, 
which used to be right near here 
in Hastings-on-Hudson. I was 
appointed to the center in 1984, 
but I had been one of their 
groupies before that,” he says.
Now Dr. Wassermann channels 
his ethical concerns into the 
lectures he delivers for the 
required medical ethics course 
that spans all four years at the 
medical school.
That his sensitivity is matched by 
sentimentality is evident in the 
scores of Commencement 
programs and yearbooks he had 
saved since 1958. All he had to 
do was look at a photograph and 
he could remember who a student 
was—something exceedingly help­
ful for alumni staff (Alas, the 
books were ruined recently from a 
downpour that breached the BSB 
roof under repair.) And his grasp 
of micro-minutiae is so keen that 
he’s become the source to end all 
sources for everything from opera 
to the West Nile virus.
Dr. Wasserman has been married 
since 1953 to his “peacenik” wife, 
Hannah. They are the parents of 
three sons—Eric ’85, a neurologist 
at the N.I.H.; Ross, a restaurateur 
in upstate New York; and Joel, a 
graduate of Brown Medical School 
who practices emergency medi­
cine at Boston City Medical Center. 
Eric is the father of their grand­
daughter, Sophia, age 9- The 
Wassermanns have always lived in 
New York City (and at a weekend 
home in upstate New York) 
despite the number of years he’s 
commuted to Valhalla. The
College has never suffered for it; 
during any snowstorm, he’s the 
first to make it in—delayed start 
or closing notwithstanding.
Ruminating at large
when it comes to voicing an 
opinion, especially in an election 
year. Dr. Wassermann has never 
been known to be shy. “Norman 
Thomas isn’t around anymore. I’m 
a knee-jerk, bleeding heart liberal,” 
he admits, leaving no speculation 
for whom he voted. When he gets 
around to the College he is no less 
frank: “We have a damn good 
medical school. The students are 
content with what we are giving 
and we know the areas that need 
input.. .1 want to continue to teach 
and even improve the high quality 
of our courses. We must continue
to encourage the faculty to 
challenge our students, because 
as the saying goes, if you don’t 
progress you retrogress. You 
should never wait for students to 
complain before making changes.”
Whether he is too idealistic or just 
plain cranky, it still seems fair to 
ask Dr. Wassermann when he will 
finally give it up. “Retirement is 
constantly in my thoughts, but I 
don’t know what to do about it,” 
he ponders. “I would be looking 
for a job just like this, but without 
the budgetary concerns and 
other assorted minutiae of being 
chairman. But when they finally 
do appoint a new chairman, I 
think it might be time to pack 
up and go home.” ■
358 Graduates Gain Diplomas at Carnegie Hall
Ready for their close-ups at the 141“ Commencement of New York Medical College are, 
from left, Rev. Msgr. Harry C. Barrett, D.Min., M.P.H., College president and chief 
executive officer; Anthony Fauci, M.D., director of the National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, who delivered the Commencement 
address; and Ronald F. Poe, chairman of the College’s Board of Trustees. (Robert Fhyd Photo)
The Heart
(continued from page 11)
cell death and enhance cell 
growth, or find the proper balance 
between the two, the future lies 
in gene therapy—treating the 
overexpression of a gene product 
or the deletion of a gene.”
Meanwhile Dr. Anversa continues 
to explore diabetic cardiomyopa­
thy and the loss of heart muscle 
cells, which he presented in 
abstract form at the American 
Heart Association annual meeting 
in November 1999. Subsequently 
published in Laboratory 
Investigation, the paper showed 
how sugar and apoptosis are 
dose- and duration-related, and 
it implicated angiotensin II in 
the triggering of cell death. 
Angiotensin, a family of peptides 
(amino acids), has the ability to 
narrow blood vessels (vasocon­
striction), a dubious claim to fame 
since sound cardiac health hinges 
on unrestricted blood flow. In 
cardiac myocytes, he found, sugar 
increased the presence of 
angiotensinogen, the precursor of 
angiotensin II. In fact, sugar 
amplified the presence of renin 
and angiotensin.
“This suggests that it is angiotensin 
II binding to its receptor, ATI, 
that induces apoptosis. It is the 
consequence of a glycosylation 
process and how glucose con­
tributes to the regulation of cell 
death and ultimately, to weaker 
hearts and cardiac myopathy,” 
states Dr. Anversa.
His bottom line is to establish that 
diabetes per se leads to cardiac 
myopathy and heart failure. Or, 
to put it “Jeopardy”-style, What 
are Piero Anversa and the 
Cardiovascular Research Institute 
well on their way to proving? ■
Spinal Cord Injury
(continued from page 7)
or surgical intervention.. .Our 
results with clenbuterol so far are 
as effective as any drug given for 
human spinal cord injuries to date, 
and that includes steroids and free 
radical scavengers.”
Next step
while animal studies proceed in 
their labs, Drs. Etlinger and Zeman 
look forward to receiving data 
from two other clinical trials that 
are planned to 
begin in 2001. The 
principal investigator 
is Chitti R. Moorthy,
M.D., professor and 
director of clinical 
radiation medicine 
at the College and 
Westchester Medical 
Center. His protocol 
calls for using patients 
between 18 and 75 
years of age with 
spinal cord injury 
from C3-L1 levels, 
resulting in complete 
loss of motor and 
sensory function 
below the level of 
injury. (Other 
patients with some 
sensory function will 
be tested separately.)
All patients will be 
treated as soon as 
they are medically 
judged stable and 
recovered from the 
injury-related “unstable” status.
Patients will get radiation in one 
trial, clenbuterol in the other. As 
they have different mechanisms of 
action, the outcomes should be 
much more intriguing. Radiation 
is expected to hinder the degener­
ation process of spinal cord injury
by minimizing the cavity that 
forms within the injured site, 
preventing fibers from reconnect­
ing. Clenbuterol appears to 
promote nerve regeneration by 
protecting surviving neurons from 
further injury and stimulating 
their reattachment.
The tempo of their research into 
the drug’s pathophysiology in 
animals undoubtedly has primed
Joseph Etlinger and Richard 
Zeman for the down time ahead. 
They will occupy the sidelines 
while physicians in radiation 
medicine, neurosurgery, neurolo­
gy, radiology and rehabilitation 
medicine take over the investiga­
tion. Actually, that should leave 
them time to figure out what else 
clenbuterol can do. ■
Supporting the spinal cord injury research are, from left stand 
ing, Hua Song, Ph.D., Tamiko Sato, M.D., Yong Feng, M.D., 
M.S., and Hong Peng, M.D. With the exception of Dr. Sato, 
who is an associate professor, all are research fellows in the 
Department of Cell Biology and Anatomy. Dr. Peng is seated 
before a cryostat, used to freeze the muscle and spinal cord 
tissue for cross section.
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Our Own Grad Directs the 
Leukemia Service and Fosters 
Research on Campus
Karen P. Seiter, M.D. ’85, carries on the tradition that 
drug trials are critical for patient care.
How do hematology oncologists 
practice medicine knowing that 
three-quarters of their patients 
with leukemia, lymphoma and 
multiple myeloma will die? Here’s 
one stereotypical answer: These 
doctors—^veterans with a track 
record of failed chemotherapy— 
stay uninvolved, utterly pessimistic 
and hard to reach, emotionally and 
by phone. How refreshing it must 
be then for patients to meet Karen 
P. Seiter, M.D., associate professor 
of medicine and director of 
Leukemia Service at New York 
Medical College and Westchester 
Medical Center. Eager and petite 
as an undergraduate. Dr. Seiter 
displays the intense but easygoing 
persona of her youth—a lover of 
music and science who could not 
decide which interest to pursue. 
But when solid M-CAT scores 
tipped the scales, she knew what 
she should do. That she made the 
right choice is evident from the 
achievements of a decade, 
enabling Dr. Seiter to attain the 
experience, credentials and 
esteem befitting the student who 
graduated first in the School of 
Medicine’s Class of ’85.
Early respect
Above all, enthusiastic and 
optimistic are words that best 
describe how Dr. Seiter treats her 
patients. This disposition was
spotted early on by none other 
than William H. Frishman, M.D., 
professor and chairman of the 
Department of Medicine. Though 
it was long before he joined the 
College faculty, his memory serves 
him well:
“I have had the opportunity to 
work with Karen Seiter on two 
occasions in different settings.
She worked with me as a medicine 
intern and resident at the Albert 
Einstein College of Medicine train­
ing program, where I was chief of 
medicine at the Einstein college 
hospital. Karen was an outstand­
ing house officer who worked tire­
lessly on behalf of her patients in a 
quiet but highly effective manner. 
She always got the job done with­
out fanfare and I rated her as one 
of the best residents I have ever 
worked with...
“Now Karen directs one of the 
most highly rated leukemia 
services in the region and the 
country. She has combined an 
outstanding career as a clinician, 
researcher and teacher.. .and she 
is a credit to New York Medical 
College and the medical center,” 
he says with pride.
Almost in disbelief. Dr. Seiter 
shakes her head, amazed at how it
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all turned out. “I had changed my 
mind so many times and there was 
nothing in my family background 
to encourage medicine,” she says. 
At Hofstra University, barely 20 
minutes from her home in 
Bethpage, Long Island, she had 
changed majors in business, music, 
chemistry and finally biology, 
causing her to scramble for the 
pre-med courses she needed to 
apply. By the time she was a 
third-year student, she had decid­
ed to do her rotations in New York 
City. And from working at St. 
Vincent’s Hospital and then-affiliat­
ed Lenox Hill Hospital, Dr. Seiter 
knew she was observing the rise 
of a yet unnamed disease.
Great unknown
“The thing I remember was AIDS 
had just gotten started. Nobody 
knew what caused it and there 
were so many patients. You had 
to put on goWns and booties to 
enter the fldor,” she recalls, though 
AIDS was ijyt to be her thing. 
“During tHe'fourth year, when we 
were allo^^d to take electives at 
other hospitals, I decided to do a 
month at Memorial Sloan-Kettering 
on hematological malignancies 
and oncology in general. I also 
went to NYU for general anatomic 
pathology because I am a visual 
person. I’m still interested in art 
and photography.”
In the end, Dr. Seiter chose 
internal medicine over surgery 
because, “I like follow-up,” she 
maintains. “In surgery you hardly 
ever see the patient again. I like 
problem solving, differential 
diagnosis—^where there can be 
20 causes for a rash—and thinking 
through a situation to make a 
diagnosis.” This lasting interest 
in medical specialties outside her 
own is something she stokes by 
regularly attending Department of 
Medicine Grand Rounds.
After graduation
“I was very happy to be 
a resident at Einstein 
[Albert Einstein College 
of Medicine].. .In city 
hospitals you had more 
responsibility, especially 
in those days. We made 
decisions and actually 
did procedures,” she 
reveals of those years 
at the Bronx Municipal 
Hospital Center, now 
called Jacobi Hospital.
Dr. Seiter followed her 
training with a three- 
year combined hematol­
ogy/medical oncology 
fellowship at Memorial 
Sloan-Kettering.
She chose the bmtal 
sub-specialty, she says,
“because I always 
wanted to take care 
of seriously ill patients.
Nothing drove me 
crazier than seeing 
people with sniffles in a clinic. 
Besides, I also had an interest in 
molecular biology, and there is a 
lot of it in leukemia research... 
Since I began practicing, there has 
been great improvement in the 
treatment of leukemia—new thera­
pies and dramatic improvement in 
outcomes and supportive care too. 
For example, in those days every
patient on chemo vomited. Now we 
have true anti-nausea medications 
like Kytril and Zofran.”
After completing the fellowship.
Dr. Seiter signed on as a clinical 
instructor at Mount Sinai Hospital. 
She also joined a small group in 
private practice. “I hated it,” she 
admits. “You go to work everyday, 
see your patients and go home. The 
next day you do it all over again...
I like to work on a research project
Karen P. Seiter, M.D. ’85
that goes on for three or four years. 
You write a protocol and begin 
treating patients. Then you get to 
analyze the results and use them to 
design further studies. After a few 
years doing research, you’re part of 
the advances being made and you 
can improve on the treatment you 
give your patients.”
An idol
The inspiration to join the thriving 
College leukemia program had 
been brewing ever since Dr. Seiter 
was interviewed for a fellowship by 
legendary leukemia expert Zalmen 
A. Arlin, M.D. “It seemed he lived 
and breathed leukemia research, 
and his passion was contagious,” 
she remembers. Dr. Arlin had 
come from Sloan-Kettering to start 
the College program, and he subse­
quently recruited Eric Feldman,
M.D., Dr. Seiter’s partner, 
who resigned two years 
ago to join another organi­
zation. “I never got to 
work with Dr. Arlin. He 
died from a brain tumor 
around the time I came in 
1992,” she says. But the 
ardor of his legacy surely 
lives on in Dr. Seiter, 
who’s treated 200 newly 
diagnosed patients since 
he died and countless 
more who have relapsed.
“Sloan-Kettering is using 
mitoxantrone, the drug Zal 
developed, in one of its 
studies based on the 
success of our regimen 
here.. .We have 12 studies 
presently underway in all 
three phases. Some are 
in-house, others are 
with pharmaceutical 
companies. The truth 
is that within leukemia 
circles, people know 
Valhalla. M.D. Anderson 
and Sloan-Kettering know 
us...This place has enormous 
potential,” says the oncologist, 
who adds that often it’s so hectic 
she thinks about taking an industry 
job. “But I know that when I’m 
off-service, it makes me realize I 
could never take a job that didn’t 




^^ricella-zoster virus ccaises chicken pox 
and shingles. Boosting immunity in adults may
in skin pigmentation and leftover 
scars as mementos of the episode. 
Still, they will pale in comparison 
to the pain that can hang on and 
on as postherpetic neuralgia, 
persecuting the aging, most 
vulnerable population. The older 
the patients are, the greater their 
risk in bearing it. In a 1996 review 
article in The New England 
Journal of Medicine, it was 
estimated that 75 percent of 
patients over the age of 70 are 
destined to suffer the torment of 
postherpetic neuralgia.
prevent herpes zoster and the dreadful pain that 
con linger forever.
Herpes zoster, better known as shingles, erupts into blisters that can itch, burn and feel 
like an electric shock all at the same time. The pain is considered to be among the worst 
in medicine.
Hardly anybody dies from shingles, but some victims almost wish they 
had after recovering with a legacy of pain. A reincarnation of the 
varicella-zoster virus (VZV) that causes chicken pox in children, herpes 
zoster is the name of a syndrome when VZV reactivates after hiding 
dormant in sensory nerves, perhaps for decades. It can reappear 
insidiously, heralding its arrival with pain that usually lasts from a few 
days to a week. When the skin eruptions follow, they evolve from a 
distinct patch of erythema to vesicles that pustulate and crust over in 
7-10 days. It may be a month before they heal, often leaving a change
“Pain is probably the most 
common complication of herpes 
zoster,” agrees John Raffalli, M.D., 
assistant professor of medicine 
at New York Medical College 
and attending physician in the 
Division of Infectious Diseases 
at Westchester Medical Center. 
“This pain can be debilitating and 
miserable for an old person to 
experience.” And there are other 
clinical syndromes associated with 
the varicella-zoster virus—myelitis, 
an inflamed spinal cord; damage 
to the nervous system resulting in 
paralysis and numbness; and 
stroke, when the arteries behind 
facial lesions are involved.
Other perspectives
Stephen Marks, M.D. ’80, associate 
professor of neurology, agrees 
“it is among the worst pains in 
medicine. Usually it’s a chronic 
burning itch, but it can also 
manifest as a brief but severe 
electric shock pain. Many patients 
have both kinds at the same time.”
The third specialist dealing with 
shingles is the dermatologist 
who tends the rash that has an 
affinity for the chest and neck. 
(The eyes are another common, 
very nasty target.) Peter Engber, 
M.D., assistant clinical professor 
of dermatology based at St.
Vincent’s-Staten Island, 
has been treating zoster in 
children and in adults for 25 
years. He became intrigued 
with the disease after seeing 
an unusual patient, a six- 
year-old boy with shingles 
whose mother claimed he 
had never had chicken pox. 
“I take this disease very 
seriously,” Dr. Engber says. 
“The impact of postherpetic 
neuralgia on elderly people 
in particular can be devastat­
ing. It can ruin their lives.”
Owing to such a dreadful 
outcome and the number 
of cases involved, it begs 
the question why medical 
science has neglected 
shingles and its aftermath. 
Nor is the infection a 
priority topic with the 
medical media, despite 
the fact that shingles can­
not be prevented, treated 
satisfactorily or cured. 
Granted, herpes zoster 
can be pampered with 
anti-virals and other 
palliatives, but relief is 
transitory and substandard. 
One solution would be 
to consider another 
approach—to prevent the 
disease altogether. The 
trouble is it will take several 




Chicken pox confers life­
long immunity to chicken 
pox, but not to shingles. 
Shingles usually confers 
immunity to shingles, 
although it does recur in 
up to 5 percent of cases.
John Raffalli, M.D., Division of Infectious Diseases, believes 
the shingles trial sponsored by the NIH, the Veterans 
Administration and Merck should yield very important 
results. The study will determine if the chicken pox vaccine 
can prevent shingles in a population over age 60.
Neurologist Stephen Marks, M.D. '80, says, “someone every 
month comes in with pain thinking he has an appendix or 
a heart attack and then a few days later, the shingles rash 
appears." There is a good chance that after the rash heals, 
the pain ofpostherpetic neuralgia will remain.
according to Dr. Marks.
There is a memory to immu­
nity that would keep herpes 
zoster under control as well 
were it not for the fadeout of 
cellular immunity that preys 
on patients of advancing age, 
and those who are immune- 
compromised from disease or 
chemotherapy. Once the 
virus makes its way to neu­
rons and nerve-associated 
satellite cells, it ultimately 
spreads to the skin via 
peripheral nerves.
(It is the skin’s appearance 
that gave shingles its name. 
Some say it came from the 
lesions that appear in bands 
or layers, like a row of shin­
gles. Others prefer a varia­
tion citing the Latin word for 
belt, cingulum, because of 
the resemblance. The letter 
“s” apparently was added 
at the end when the word 
made its way into the 
English language.)
Researchers believe 
postherpetic neuralgia pain 
results from injury to the 
peripheral nerves and an 
exaggerated response of 
the central nervous system. 
The growth of axons after 
the lesions heal produce 
nerve sprouts that also are 
prone to hyperexcitability. 
These changes may be so 
complex that no single 
therapeutic agent is capable 
of restoring the system to 
normal. Doctors have tried 
everything from B vitamins 
to snake venom and a 
multitude of interventions 
in between. The first 
drug actually approved 
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norepinephrine and serotonin. The rationale is to relieve pain by increasing the 
inhibition of spinal neurons involved in pain reception. The favored tricyclics 
are amitriptyline and desipramine. Another useful though limited agent are the 
anticonvulsant drugs; phenytoin, valproate sodium and carbamazepine can overcome 
shooting pains, but they cannot mitigate the chronic burning pain of postherpetic 
neuralgia. However, a new Japanese study showed that a series of four spinal 
I injections of a mixture of lidocaine and the steroid methylprednisolone signifi- 
I candy reduced pain in patients who had suffered for at least one year; the pain 
.< reduction has so far lasted two years.
The most radical alternative is the neurosurgical procedure, a last resort for 
intractable pain. Electrical stimulation of the thalamus, and a cordotomy to 
interrupt the neurologic pathway between the thalamus and the spine, is one 
option. Another is counterirritation, a procedure utilizing ethyl chloride in spray 
form to produce a freezing sensation, along with electrical nerve stimulation of 
the skin to help small inflamed fibers in the spinal cord return to normal.
i
I
Acyclovir (Zovirax), the first drug to overcome a virus, 
won the 1988 Nobel Prize for Medicine or Physiology 
for its inventors at Glaxo Wellcome. Although it can 
reduce pain when shingles erupts, acyclovir does not 
alleviate the distress of postherpetic neuralgia.
New approach
In 1995, Merck received FDA approval of its VARIVAX vaccine to prevent the 
varicella-zoster virus, previously responsible for an estimated 4 million cases 
of chicken pox, 11,000 hospitalizations and 100 deaths each year in the U.S.,
according to the Advisory Committee on Immunization Practices. The vac­
cine is effective in preventing chickenpox, not only in children, but 
also in adults who’ve never had the disease. Theoretically, 
VARIVAX should also boost immunity in older people whether 
they have had chicken pox or not. Ergo, if the varicella virus 
can be foiled, shingles can be prevented. Additionally, several 
studies show that the risk of getting zoster does not appear to 
be increased in persons getting the vaccine.
Administration (FDA) for postherpetic neuralgia was 
capsaicin, the substance in chilies that makes them 
hot. Regrettably, one study shows capsaicin cannot 
be tolerated by up to one-third of patients due to a 
burning sensation when applied in cream form.
Other therapies
The first medications to safely block any virus were 
the nucleoside analogues, or antiviral drugs. Acyclovir 
(Zovirax) was such a breakthrough that it won its co­
discoverer, Dr. Trudy Elion, a shared Nobel Prize for 
Medicine or Physiology in 1988. Acyclovir, and next 
generation famciclovir and valacyclovir, can signifi­
cantly reduce pain after onset of zoster, but some stud­
ies show they are of no use in postherpetic neuralgia.
There are doctors who prefer to first treat their 
patients conservatively. The old standbys—analgesics 
and anesthetics—include aspirin, ibuprofen, naprox­
en, acetaminophen, topical formulations of aspirin and 
indomethacin with ether, and lidocaine (Lidoderm) 
used topically as a patch. When something stronger is 
called for they prescribe neuroactive agents like the 
tricyclic antidepressants, which block the reuptake of
Dermatologist Peter Engber thought the opposite when 
his six-year-old patient (vaccinated at four) walked in 
with shingles despite his mother’s insistence that he never 
had chicken pox. Dr. Engber explained there were two 
possibilities: either her son did have chicken pox without 
her knowing it, or he got shingles from the vaccine. DNA 
typing proved the child’s zoster virus was a wild strain 
that did not match the type used to make the vaccine, so 
Dr. Engber had his answer. The VARIVAX vaccine did not 
protect the boy from zoster. Whether he got the mild 
case of chickenpox before or after the vaccination will 
never be determined.
Shingles is not so passive, though perhaps its days of 
torment are numbered. In March 1999, a consortium 
of the VA Medical Centers, Merck and the National 
Institute of Allergy and Infectious Diseases began 
seeking 37,000 volunteers to test a more potent version 
of the original chicken pox vaccine. Enrollment is 
open through the summer of 2001; as of November, 
more than 25,000 were registered. To participate in the 
Shingles Prevention Study call the national screening line 
at 1-877-841-6251. For questions about the trial call 
Heather Williams, RN, national study coordinator, 
at 1-858-552-8585, ext. 4638. ■
WHO STAND OUT FROM THE CROWD
Whether graded A B C or pass/fail, ceriain students in every graduating class 
rise to the top with the best grades, the most related outside activities and 
display particular interests that earn them the respect and admiration of their teachers. 
The criteria in each school may vary, but ultimately they single out 
those special persons who merit recognition for going the extra mile.
In the Class of2000, these scholars came away with their schools’ top awards 
at senior honors ceremonies and much more than their’diplomas.
School of Medicine School of Basic Medical Sciences
WILLIAM CULLEN BRYANT AWARD 
winner was Renee C. Comizio, M.D., president 
of the Student Senate. Established by the Board 
of Trustees to honor the president of the board 
for 10 years, this award is presented to the 
graduate who has achieved a distinguished 
academic record and has contributed outstand­
ing service to the College community and 
student body. Dr. Comizio, the daughter of 
Robert J. Comizio, M.D. ’63, is doing a residency 
in general surgery at Beth Israel Hospital 
in Boston.
MARTHA LUCAS PATE, PH.D. 
MEMORIAL AWARD 
went to Matthew J. Scholer, M.D., Ph.D. 
Established by the Board of Trustees in memory 
of the trustee of the College, this honor is 
awarded annually to a graduate student who 
has demonstrated academic excellence and 
leadership in social and humane concerns in 
medicine, science or health. Dr. Scholer, who 
earned his doctorate degree in pharmacology, is 
doing his residency in emergency medicine at 
North Carolina Memorial Hospital in Chapel Hill.
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Graduate School of Health Sciences
ACADEMIC EXCELLENCE AWARDS 
are presented in three areas to graduates who, 
in the judgment of the faculty, have exhibited 
excellence in their academic work over the 
course of their graduate education. From left 
are Diana Jean Sinclair Cunningham, M.P.H. in 
health policy and management; Kevin Robert 
Cummings, M.P.H. in public health; and Jennifer 
Jordano, M.S. in physical therapy. The winners 
coincidentally represented all facets of the 
College community. Cunningham is associate 
dean and director of the Medical Sciences 
Library; staff member Cummings is the university 
webmaster; and Jordano was a student in one of 
the school’s newest programs.
Chironian will keep in touch...
Here’s what the two ’99 grads we profiled had to say after one year as novice M.D.s...
Jacqueline Bender,
M.D. ’99, at North 
Eastern Ohio College 
of Medicine in Akron, 
says: “Things are going 
pretty well. Now that 
I am in the QR more 
often work IS more fun. 
(I try, of course, to 
work with the surgeons 
who listen to Motown 
while they operate.) 
Once in a while a 
patient is shocked to 
have a young female 
urologist, but they end 
up letting me take care of them once they get over 
their initial surprise. Most of the cases I am doing 
are the smaller ones (bladder biopsies and laser 
lithotripsy of kidney stones) but of course each year 
of residency brings more responsibility.. .1 still man­
age to swim occasionally (thus counteracting the 
free food at work). I have been dating a resident 
in another program since last year and that’s going 
pretty nicely so far.”
Robert McCormick,
M.D. ’99, confides he 
finished his intern year 
with sanity intact. “I am 
at UCLA slaving away at 
a combined emergency 
medicine/internal 
medicine residency 
and enjoying the pace 
changes of switching 
between these depart­
ments every three 
months. I enjoy the 
puzzle solving of the 
internist as well as the 
hands-on procedural 
style of the ER.. .There are many NYMC grads on 
both house staffs, so I often find myself in the 
company of old friends.. .The hard work at the 
hospital is contrasted with the fun I have at home. 
As residencies go, the program allows a very 
generous amount of time off which I spend with 
my wife and two growing boys. The hardest part 
of my program is supporting a family on a resident’s 
salary, so to help make ends meet I referee 
soccer.. .Em very happy to be back in California 







Aiice M. Baruch, Ph.D, '82, 
M.D., is nurturing phase lil 
triais of the anti-fungai 
drug voriconazoie.
It takes infinite patience and great dedication to work 
on getting a new product for a drug company 
licensed. But it’s no problem for Alice M. Baruch,
Ph.D. ’82, M.D., the designated Product Physician and 
Medical Director at Pfizer Pharmaceutical Group,
Pfizer Inc., in New York City. She’s done it all before. 
Though her title may not sound provocative, don’t be 
fooled. Dr. Baruch is so happy in her job that she 
does “cartwheels on the way to work” for the hottest 
company in the industry. At Pfizer, she has oversight 
for phase Illb/IV (later phase III and post-approval) 
clinical trials of voriconazole, and then educating the 
medical liaison personnel and the marketing force. 
Moreover, Vfend®—^the proprietary name for 
voriconazole—is targeted to eliminate serious fungal 
infections, a branch of infectious diseases with 
precious few drugs to overcome their highly evolved 
cells. And since four rivals are also working on 
anti-fungals, the product physician will only tell you
Alice M. Baruch, Ph.D. ’82, M.D.
that trials are “ongoing in every populated continent 
except Antarctica.” Dr. Baruch could give you more 
details, but then she would have to find another job.
It’s worth it
To bring a drug to market takes an average of 10 
years, she says. Patents are only good for 17 years, 
and the clock starts ticking the day of discovery. The 
remaining seven years are devoted to conjuring up 
more studies to find a new use for the drug, and so it 
goes. There is no downtime for Dr. Baruch, who 
chooses to work only on infectious diseases. “We 
make people better,” she explains with a smile. “We 
cure them.” Then why, having an M.D. degree, does 
she not practice medicine?
“I hated clinical practice,” Dr. Baruch admits. “It was 
in a hospital with not enough supplies. But that 
aside, I like my hours off, and you can’t do that as a
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practicing physician. You’re on 
call 24 hours, 7 days a week, 365 
days of the year. Here I get a 
vacation, with nights and week­
ends off.” And she doesn’t even 
work past 5:30 p.m., which sounds 
privileged until she informs that 
she rises at 4 to be in the office 
by 5:30 a.m. “Pfizer is a great 
company and a great company to 
work for,” is how she justifies 
her 12-hour day.
City gal
Dr. Baruch signed on with Pfizer 
in 1998, with phase III trials of 
voriconazole well underway. This 
was her return ticket to Manhattan, 
the only domicile she feels is 
worth calling home. “I love New 
York. I get lonely when I’m not 
with my friends and family,” she 
claims of her fortitude in leaving 
other good jobs in New Jersey 
with Janssen Research Foundation 
in Titusville, and Hoffmann-La 
Roche in Nutley. But that doesn’t 
mean she is always residing at 
home, now on the Upper East 
Side. Dr. Baruch travels extensive­
ly because, “a global development 
project warrants a great deal of 
travel,” she says, recently having to 
visit Argentina, France, India,
Brazil and make her way across 
Europe within a short period of 
time. She is one of 250 employ­
ees, and one of four in the New 
York group, who are readying the 
drug for FDA submission.
In a sidebar to her job, she wears a 
beeper to cope with an emergency 
request for voriconazole. “An 
emergency can be a lesion in the 
head, for example. But the patient 
has to fail all the available anti- 
fungals before we can release the 
drug,” she advises, which comes in 
oral and IV formulations. “We get 
requests for compassionate use 




with a smile. 
"We cure them.
I have to make the decision to 
give or not to give. The needy 
patients usually are immune- 
compromised—^from chemothera­
py or bone marrow transplants for 
leukemia and lymphoma.”
Whence anatomy
This is all a far cry from the Ph.D. 
dissertation she wrote on the 
neonatal development of one 
specific auditory area of the brain 
in mice for the Department of 
Anatomy and Cell Biology in the 
Graduate School of Basic Medical 
Sciences. “I received a great 
medical [science] education at 
the College,” says Dr. Baruch, 
mentioning that her thesis advisor 
w^ Robert Browner, Ph.D., 
associate professor and co-director 
of neurosciences from 1973 to 
1991. He is currently a biotech 
consultant who remains a good 
friend after 25 years, says Dr. 
Baruch. Calling her a hard worker. 
Dr. Browner must be alluding to 
her final year in Valhalla when 
she was concurrently writing the 
dissertation and coping with the 
first year of medical school at 
the College of Physicians and 
Surgeons of Columbia University. 
“Not only did they waive the 
anatomy course for me, but also 
asked me to teach it because of 
my Ph.D.,” she says.
After graduation in 1985, Dr. 
Baruch did an internship and
residency at New York Hospital, 
followed by a fellowship in the 
Division of Infectious Diseases, 
Department of Medicine, at 
Columbia-Presbyterian Medical 
Center. But after two more years 
as an instructor and an assistant 
attending physician in the Mount 
Sinai system, she opted out for 
clinical research at Hoffmann-La 
Roche. Her modestly worded CV 
shows she wrote the new drug 
application to the FDA for 
saquinavir (Invirase®), the 
first HIV protease inhibitor 
approved worldwide.
Maternally proud
“Saquinavir was my baby and the 
first on the market,” she beams.
“It became part of the basic thera­
py for HIV, using multiple drugs to 
keep the viral load under control.” 
Which makes one wonder, when 
so many drugs are being given, 
and the infection isn’t obvious, 
when do you suspect a fungus is 
the cause? Dr. Baruch replies, “If 
you’ve been giving antibiotics for 
four days, and the patient is still 
neutropenic and febrile, we know 
that 5 to 10 percent of these cases 
will have a proven fungal infec­
tion. It can be anywhere in the 
body—the brain, the lung—^you 
have to look for it, with blood 
cultures, x-rays and CT-scans.
Any fever over 100.8F with no 
white cells is dangerous.”
Lest you wonder whether Dr. 
Baruch is in fact treating infections, 
she anxiously puts any such 
thought to rest: “I was responsible 
for making sure that the U.S.-based 
phase III trials of voriconazole ran 
appropriately, that the data were 
received, and that they were 
available for Pfizer’s new drug 
application on time and with 
good quality. Now I’m on to 
phase Illb/IV.” B
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Health Sciences Grad 
Plys Her Trade in Nirvana
eople who work 
in social services 
mostly help the needy 
and disadvantaged.
Greenwich Department of Health managed to come up with 
enough vaccine to inoculate all the elderly who wanted it, making 
it available in various locations around town. “People here want 
service and they are willing to pay for it.. .We have top quality 
programs,” she says. “We run the office like a business.”
This can be one perception, but it hardly 
applies to Caroline C., Baisley, B.S., M.P.H. 
’96. Before earning her degree from the 
Graduate School of Health Sciences at New 
York Medical College, she was already 
protecting the health and environment of 
the Town of Greenwich. This well-bred 
community on Connecticut’s Long Island 
Sound gold coast is celebrated for 
cultivating the elite of business, baseball 
and the arts, and it surely has rubbed off 
on her. Indeed, the sophistication 
attendant to her daily routine is sometimes 
over stimulating to the point of surfeit.
“Not a day goes by that I don’t want to 
come to work,” she swears. “As director 
of health for Greenwich, I have a very 
stressful position, but when I get to 
the office I am completely absorbed. 
Suddenly it’s time to go home before I 
know it, and I never get everything done 
because there just isn’t enough time in 
the day.”
Perhaps that can be ascribed to the way 
Baisley runs the department with the 
glamour and efficiency of the CDC. By 
way of illustration, the influenza vaccine 
was in short supply everywhere this year, 
and Greenwich was forced to direct 
residents under age 65 to visit their own 
doctors. Despite the shortage, the
In the loop
Baisley says she’s not a micro-manager, but relishes getting into 
the action herself. In an effort to estimate the rate of West Nile 
virus infection in the community, health workers had to ask 
residents door to door for blood samples. A reluctance to partici­
pate provoked Baisley to ask a local newspaper to encourage the 
community to comply and have blood drawn. After an article and 
photo appeared on the front page, the donors came out of hiding
Caroline Baisley, B.S., M.P.H. ’96
and there were enough volunteers 
to get the study going.
Baisley is keenly aware, and 
still rather astonished, at how 
“fortunate I am to be in this place. 
I’m more than just a worker and 
I’m good at what I do, but I can’t 
see doing it in any other communi­
ty. This makes me want to do my 
job even better,” allows the 
Yonkers, N.Y., native who never 
got a bump on her way up the 
ladder. Nineteen years ago,
Baisley took her B.S. in biology 
from Mercy College in Dobbs 
Ferry, N.Y, and her credentials 
as an environmental health 
consultant for the New York State 
Department of Health, to Green­
wich. As the town’s Registered 
Public Health Sanitarian, she 
exercised a mandate to inspect 
and enforce compliance with the 
rules and regulations governing 
food, potable water (wells, water 
treatment devices), housing, day 
care, bathing, sewage disposal, 
environmental pollution, solid 
waste/pest control, and barber 
shops/beauty salons.
New pew
In 1989 her promotion to director. 
Division of Environmental Health 
and Laboratory was as important 
as it sounds. Greenwich is in 
Fairfield County, a designation 
useful only for location, area and 
zip code. In New York State, 
counties oversee the health and 
welfare of municipalities via a 
layer of government officials and 
big budgets. Connecticut did 
away with all that decades ago and 
except for the state judicial system, 
each town runs its own show.
So when she assumed complete 
responsibility for clinical and labo­
ratory operations in Greenwich,
Baisley had no one else to bail her 
out. Turns out she didn’t need to. 
She did the job for seven years 
with a budget of around $450,000.
Director of Environmental Health 
was her next title, as she directed 
a comprehensive environmental 
health program for the town’s 
59,000 citizens. It was also in 1996 
that she earned her M.P.H. degree, 
a rung she had to pass to continue 
advancing. The opportunity for 
top spot came sooner than she 
expected when her boss retired as 
director of health due to illness.
Keeping up
“Greenwich is like no other place 
you’ve ever lived,” says Baisley, 
who resides a few miles away in 
Norwalk. As health director she 
administers a $2.5 million annual 
budget, with a nursing program 
accounting for half of that.
“.. .What we do best is prevention 
and promotion of healthy living 
by giving access to health care for 
everyone. We also are a resource 
for all the town agencies and 
advisors to Nathaniel Witherall 
[nursing home], she explains.”
Her purview ranges from dental 
health to HIV and STD information 
and services as well as the 
environmental issues that apply.
Of course Baisley faces the same 
problems as health officials in 
surrounding communities and 
she has the budget to treat the 
unexpected just as easily. But in 
Greenwich, ancillary issues have a 
way of overriding other concerns. 
It’s Lyme disease and how to get 
rid of deer that have already found 
their way to the main shopping 
street. (Don’t even ask about the 
geese!) It’s providing health care, 
but with an emphasis on teenagers
and the elderly, not on single 
mothers. And it’s the noise gener­
ated by two highways, the flight 
paths of three airports and the din 
of thousands of leaf blowers, 
whose use finally was restricted to 
the fall leaf pick-up.
More mainstream
Greenwich has seen an increasing 
incidence of asthma, aggravated 
by a high ozone count and air 
pollution, and officials anticipate 
the arrival of the West Nile virus 
(300 dead birds and hundreds of 
mosquitoes were found to be 
infected last summer). There also 
has been an ongoing fear of rabies 
since 1995, when a Greenwich 
youngster, Maria Fared, died of a 
bat-born strain. “It was the first 
case of rabies in the state in 60 
years,” says Baisley. (Maria 
Fared was correctly diagnosed 
at Westchester Medical Center 
shortly before she died. The 
new Children’s Hospital under 
construction there has been 
named in her memory.)
Assured and deliberate, even at the 
end of a long day, Baisley enjoys 
discussing her “uneventful rise to 
stardom in public health. I never 
envisioned myself to be where I 
am today,” she says. Perhaps the 
College contributed to her success? 
“It was an excellent program,” she 
replies. “The faculty were very 
committed. They didn’t waste our 
time or theirs. My experience with 
all the teachers was outstanding...
I think I’ve been in the right place 
at the right time, especially when 
it relates to Greenwich. It’s been 
just the best experience being 
associated with a community that 
has these resources. I hope to 
stay here until I retire.” ■
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25 Years Later, ’75 Graduates Recall the 
Great Experiment and How They Endured 
the Upheaval of Mud and Moving
When the Classes of '75A and B cele­brated the 25"' anniversary 
of their graduations from 
New York Medical College 
last spring, the cocktail 
party conversation ranged 
from medicine in the 
era of managed care to 
the new medical college 
building, to reminiscing 
about lectures in Hetrick 
Hall. Although this mile­
stone commemorated 
their successful completion 
of medical school, the 
forces that shaped the 
experiences of 273 men 
and women had actually 
been initiated 30 
years ago.
Five years before the 
members graduated, the 
Carnegie Commission on 
Higher Education had 
issued a dire pronounce­
ment to the leaders of 
medical education 
programs nationwide:
"The United States faces 
one serious manpower 
shortage and that is in 
health care personnel."
The commission urged 
medical schools to 
establish university health 
science centers, increase 
their student population 
and institute a three-year 
medical school curricula.
New York Medical College 
responded with an 
ambitious initiative— 
the development of an 
academic medical center 
in Westchester and 
a concerted effort to 
increase the number of 
its graduates. "If we are 
to reconcile the shortage 
of physicians with the 
increasing demand for their
33 Members of the Class of '75A at their 25“' Reunion i,"
The Class of '75A concluded a major era in the College's history: they 
were the last class to attend lectures in Hetrick Hall or participate in labs 
in the Cullen Research Building, the academic hub of the College, located 
on 5* Avenue and East 106"' Street in New York City. Unlike the Class of 
'75B, who were known as "The Pioneers," the Class of '75A had no particu­
lar name. One alum noted, “We were just trying to survive." Members of 
the Class of '75A traveled from 15 states to become reacquainted with their 
classmates. Robert Floyd Photos
Class of '75B at their 25"' Reunion
The first NYMC class to complete medical school in three years and the 
first group of students to study at the Valhalla campus were known as 
"The Pioneers." Traveling from 14 states (from as far away as Washington, 
California and Colorado and as close as Yonkers and White Plains),
32 Pioneers reunited with their classmates at the Plaza Hotel.
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Dr. Sean Practices Survival 
Instead of Neurology on TV
when Sean Kenniff, M.D. '95, read his horoscope on 
October 8, 1999, he was instantly struck by the prophecy 
and power of the message: Let go of encumbrances that hold 
you back needlessly. Display imagination and courage. 
Proceed in your own way.
A member of a busy neurology practice on Long Island,
Sean (as he was to be known by millions) had become 
disillusioned with the economic and business demands of 
medicine. "I was working 90 hours a week, caring for patients 
with serious neurologic disorders, people with brain tumors or 
those who had suffered strokes. But because of managed care 
requirements, I could only devote 15 minutes to each patient.
I didn't want money to be my bottom line. That's not how 
I wanted to spend the next 20 years of my life," he said.
Within days of informing the senior physicians that he would 
leave the practice in two months, that astrological message 
appeared, suggesting he pursue a new path. He had also read 
a Time magazine article that described "Survivor," a new CBS 
series that would televise, in 13 weekly episodes, the experiences of 16 Americans marooned for 39 
days on a remote tropical island off the coast of Borneo. Deprived of 21“ century amenities (like food 
and shelter) and forced to cope with relentless heat, hordes of rats and poisonous snakes, the cast­
aways would compete in periodic tests of their physical stamina, athletic prowess and creativity.
After each episode, one participant would be voted off the island by the others at a tribal council and 
the last survivor would win $1 million.
"Eureka!" Sean recalls exclaiming. "That's for me!" One of 6,100 applicants, he transformed his 
shower stall into a rainforest for the application video he submitted, and indicated that his preference 
for political office would be First Lady. "I knew they wanted smart, edgy responses to the questions," 
he strategized. After a series of interviews in New York and Los Angeles, he was picked. "I received 
the producer's phone call in mid-January, two weeks after I left the neurology practice."
The only physician in the group, Sean was acutely aware of the medical risks of this adventure.
"Some of the most poisonous snakes in the world, either neurotoxic or hemotoxic, inhabit this 
island," he said. The rats and snakes invaded the beach every night, crawling through their campsite 
and around the sleeping survivors. A member of the Tagi tribe, Sean subsisted on fish, but maintains 
"we were always starving." He lost 22 pounds during his stay on the island and endured equatorial 
heat—the averagq^daytime temperature was 106 degrees—dangerous lightening and torrential storms 
with "buckets arid buckets of rain." He also swallowed the Malaysian Butok, a live beetle larvae, 
in an early competition. Sidestepping snakes and completing the physical challenges may have 
been the easiest part of the ordeal on the island of Pulau Tiga. The definitive challenges were to 
project an aura of charm and cooperativeness, form delicate alliances with team members and craft 
complex power strategies to assure that he would "survive" tribal council and stay on to win the 
$1 million prize.
Sean Kenniff, M.D. '95
Sean Kenniff, M.D. '95 (back row, third from right) and the 15 other members 
of “Survivor."
Although he did not survive to win the $1 million and a new 
car, Sean maintains that his participation on a show watched 
by 50 million viewers was one of the major experiences of 
his life. "I'm 30 years old," he said. "I'm a physician and I 
was on the number one television show in the country." The 
highlight was winning a night on a luxury yacht, where he 
enjoyed a gourmet dinner, a hot shower and a surprise 
reunion with his father. Sean describes their evening together 
as "the most memorable event of my time on the island."
Now recognized and known by millions of viewers as "Dr. 
Sean," he is the medical reporter on the nightly television 
show "Extra" and he recently played a doctor on "The 
Guiding Light." "I can use my fame and notoriety to draw 
attention to serious medical issues and reach millions of peo­
ple through one television program," he told Matt Lauer on 
"The Today Show." He is not, however, lured by the prospect 
of a full-time career in television. "Medicine is my calling," 
he said. "My life outside of medicine is empty. Caring for 
people is the meaning of my life." ■
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Bella Singer, M.D. '31 at graduation
To steal moments out of time 
In quiet thought and deep reflection 
Means not to squander 
The lean hours of each precious day. .
Beyond denuded bones or scattered dust 
To shape once more 
The spirit and flesh into a living body 
That permeates the mind with memories...
Bella Singer, M.D. '31, treasures every 
moment of her precious days, spending them 
in pursuit of passions and interests that she 
has nurtured since childhood. After practic­
ing radiology for 40 years, Dr. Singer has 
devoted her retirement to music, art and 
writing poetry. A resident of the Byron Park 
Retirement Residence in Walnut Creek, Calif., 
she divides her time among playing classical 
piano, painting in oils and water colors, and 
writing free verse. She has written over 
200 poems; some are included in a bound 
collection of ones that were bestowed upon 
friends and colleagues.
"I started to write poetry in the first year of 
medical school," Dr. Singer recalled, "inspired 
by George Stein, who also wrote poetry. We 
became friends and I helped type his poems 
which were submitted for publication in the 
Daily News." Drs. Singer and Stein married 
in their fourth year of medical school, and 
eventually moved to California. Between 
juggling the initial demands of residency 
training and later, the responsibilities of chief 
of radiology at the Walnut Creek branch of 
Kaiser Permanente Hospitals—and raising her 
children Anne and David—she had little time 
to write poetry. "I began to write poetry in 
earnest after my husband's death. His death 
occurred ten years ago. He was nearly 
84-years-old."
We gather to ourselves 
The essence of loved ones gone 
And name it immortality.
Imagination takes the leap
Dr. Singer, who recently celebrated her 95* 
birthday, is a pianist. She prefers to play only 
classical music, generally choosing Schubert, 
Beethoven, Bach and Brahms, she says.
"I am in the process of making dubbings 
of the master tape I made recently of 
Beethoven's entire Moonlight Sonata.
I have always loved a challenge!"
Her other passion is art. "Painting in oils, 
but mostly in water colors, have been of 
keen interest to me. I enjoy drawing in pen 
and pencil, too," she added. Unlike the 
piano, which she began studying at the age 
of seven. Dr. Singer never took an art lesson. 
"My travels everywhere to museums and 
cathedrals taught me much," she noted.
"I also learned from my art books. All my 
relatives on the east coast have decorated 
their homes with my art."
Although she has glaucoma (she is blind in 
one eye) and impaired hearing, she does not 
allow them to limit her pursuits. "I lead an 
active and busy life, despite my infirmities," 
she reports. "I do the things I enjoy. I see my 
family of children, grandchildren and great 
grandchildren. I do not know the meaning 
of loneliness." ■
...Renewal comes each year 
In budding yellows and light greens.
So must the spirit that lives in Man 
Rejoice in the vigor of the mind 
That blossoms ever In boundless thought 
To the very end of time.
S/nyer, 9K.Q). ’31 
7^£ysician., CPoel.^ 
CPainier., CPianisi
Chironian asked Dr. Singer to 
share some of her medical school 
memories from seven decades 
ago. Following are excerpts of 
her recollections:
When I entered New York Medical 
College in 1927, it was named the 
New York Homeopathic Medical 
College and was located on 67'' 
Street between Second and Third 
Avenues. In our second year, the 
name "homeopathic" was dropped 
and our school was given an 
improved rating as an authentic 
medical college.
On our first day of anatomy class, 
100 medical students—97 boys and 
3 girls—marched into a large room 
where we witnessed the shocking 
scene of 25 NUDE, DEAD BODIES, 
rsdemingly all male, laid out on slabs. 
The anatomy professor shouted out 
gruffly "Get busy! Eour students to a 
body and oil those bodies." The 
female students were too frightened 
to touch the body. Another shout 
from the professor shattered the 
silence. "You ladles—get to work 
on that body right away!" Humbled 
and embarrassed by this command, 
we did just that.
A comic, but gruesome twist 
occurred during the skull dissection. 
One well-worked over skull was 
hidden inside the belly of a corpse 
and later used by some students In 
their own dissection. None of the 
examiners suspected this ruse.
After months of emphasis on anato­
my, we got to the point where we 
could eat our sandwich lunches in 
the company of those dead bodies.
There were no accommodations for 
students at the medical school. We 
traveled, by long subway rides, to 
apartments in either upper 
Manhattan, the Bronx or Brooklyn. 
During final examinations, we all 
rented a brownstone to avoid 
wasting so much time and effort 
on subway rides.
Our graduation took place In 
Carnegie Hall in 1931. Twenty-five 
boys flunked out, but all the girls 
graduated. My classmates, Elizabeth 
and Marion, and I received a great 
round of applause when we received 
our degrees. At that time, girls were 
considered special to graduate as 
doctors of medicine.
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Alumni Celebrate Colleagues*
Members of the Classes of 1950, '75A and '75B gathered at the Alumni 
Association gala held in May at the Plaza 
Hotel to celebrate their class reunions 
and the achievements of three alumni, 
Bernard V. Wetchler, M.D. '50, Nicholas 
F. LaRusso, M.D. '69 and Dennis J. 
Allendorf, M.D. '70.
Bernard V. Wetchler, M.D. '50, recipient 
of the 2000 Certificate of Achievement, 
has devoted his professional career to 
advancing the field of anesthesiology. 
During his 40 years of private practice in 
Peoria, III., he served as director of the 
departments of anesthesia and ambulatory 
surgery at the Methodist Medical Center 
of Illinois, and chief of the division of 
anesthesia at the University of Illinois 
College of Medicine. Currently clinical 
professor of anesthesiology there, he is 
medical director of Vital Signs, Inc., an 
anesthesia, respiratory and critical care 
products company.
In addition to fulfilling his clinical and 
teaching responsibilities. Dr. Wetchler 
founded the Society for Ambulatory 
Anesthesia and was its first president. He 
is also the past chairman of the executive 
committee of the World Federation of 
Societies of Anesthesiologists, and past 
president of the American Society of 
Anesthesiologists and the Illinois Society 
of Anesthesiologists. His book.
Anesthesia for Ambulatory Surgery, 
is recognized as the premier text 
on the subject.
Dr. Wetchler has won numerous awards, 
including the Distinguished Service Award 
from the Society for Ambulatory 
Anesthesia. In 1999, the New York State 
Society of Anesthesiologists bestowed 
upon him its highest honor: the 
Rovenstine Lecturer for its 
Postgraduate Assembly.
"It's hard to realize that it's been half a 
century since my graduation from New 
York Medical College," Dr. Wetchler 
said after receiving his Certificate of 
Achievement from Louis E. Fierro, M.D. 
'60, President of the Alumni Association. 
"We were the first post war class and I 
want to thank my classmates for guiding, 
nurturing and tolerating a socially imma­
ture young man. Without your help, I 
might not have been here this evening."
"You brought to the office of president of 
the Alumni Association a vision of the 
College and its alumni as that of a true 
family, you have succeeded remarkably in
Above: Ralph A. O'Connell, 
M.D., provost and dean of the 
School of Medicine, is joined by 
Alumni Association honorees 
Dennis J. Allendorf, M.D., '70, 
Nicholas F. LaRusso, M.D. '69, 
and Bernard V. Wetchler, M.D. 
'50, as well as by Louis E.
Fierro, M.D. '60, president of 
the Alumni Association, and 
Rev. Msgr. Harry C. Barrett, 
D.Min., College presi­
dent and CEO. Robert Floyd Photos
fulfilling that vision," said 
Dr. Fierro as he presented 
the 2000 Medal of Honor 
to Dennis J. Allendorf, M.D. 
'70. "Your devotion to 
making the ties that bind 
the alumni and their 
College mutually beneficial 
has yielded the ever-increas­
ing support and active 
participation of alumni 
from across the country."
Dr. Allendorf served as 
president of the Alumni 
Association from 1997 to 
1999. During his tenure, 
more alumni participated in chapter 
meetings, attended alumni gatherings 
across the country and, according to Dr. 
Fierro, "more than ever, felt that they were 
part of a family." More alumni serve as 
members of the Board of Trustees and on 
the President's National Advisory Council,
DREAMS COME TRUE AT COMMENCEMENT 2000:
Robert Comizio, M.D. '63 and Renee Comizio, M.D. 2000.
"I always dreamed that one of my kids would go into 
medicine," said Dr. Comizio. "Seeing my Dad practice has 
made a difference. I knew that I would be a doctor from 
the time I was a child," said the daughter, returning the 
compliment. Any words of advice from father to daughter? 
"Be a good doctor. Remember the welfare of your patients 
always comes first," he responded. How they care for 
patients is where the Comizios will part. Dad recently retired 
after 30 years practicing internal medicine. Renee is in 
her first year of a four-year general surgical residency at 
Beth Israel Deaconess Medical Center in Boston.
and more children of alumni attend the 
College. "The number of entries for 
Milestones, the Alumni news section of 
Chironian, has increased from a river to a 
flood," Dr. Fierro noted.
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Achievements and Contributions
"My success reflects the training I 
the learned intellectuals I've been
FATHER AND SON AT THE PLAZA 
HOTEL: Hugo Gruendel, M.D. '50,
celebrated his golden anniversary 
of graduation from the College with 
classmates at the Plaza, accompa­
nied by his son, John Gruendel, 
M.D. '87. Dr. Gruendel, pere, 
practices internal medicine in New 
Rochelle, N.Y. Dr. Gruendel, fils, 
is a cardiologist in Carmel, N. Y.
Clinician, researcher, author, academician, teacher and adviser. Alumni 
Association Medal of Honor recipient Nicholas F. LaRusso, M.D. '69 
has accumulated an extraordinary record of professional achievement 
and contributions to the field of gastroenterology since graduating 
from the College 31 years ago.
A SPECIAL ANNIVERSARY: 22 members of the Class of 1950 traveled from as far away as the island 
of Jamaica to receive their Gold Diplomas at the Plaza Hotel reception. The alums reminisced about 
College life a half-century-ago, chatted about the rewards of practice and the joys of retirement, and 
renewed old friendships. "You are now emeritus members of our Alumni Association," Louis Fierro, 
M.D. '60, president, told them. "This is a very big milestone."
In addition to increasing alumni 
participation in the governance and 
life of the College, Dr. Allendorf also 
stimulated their financial support. In 
1999, the Alumni Association donated 
$2 million to endow a chair in biochem­
istry, the first in the history of the College 
and the largest contribution ever made 
by alumni.
In accepting his award, Dr. Allendorf 
turned his attention to the newest 
members of the Alumni Association, the 
Class of 2000. "Over the next 40 years.
you will touch the lives of more than 
10,000 patients," he said. "Learn the art 
of lingering and choose to linger at your 
patient's bedside. Just your presence in 
the room of a sick patient is comforting."
Besides having a private practice in New 
York City, Dr. Allendorf is an attending 
pediatrician at New York-Presbyterian 
Hospital and at St. Luke's-Roosevelt 
Hospital Center, where he serves as 
director of inpatient services and 
pediatric education.
received at outstanding institutions and 
privileged to work with," Dr. LaRusso 
said. "Be courageous and involve 
yourself in your patients' lives," Dr. 
LaRusso told the Class of 2000. "You 
can't always cure them, but you can 
comfort them."
Former chairman of the division of 
gastroenterology at the Mayo Medical 
School, Clinic and Foundation,
Dr. LaRusso nurtured the division 
into its position as the premier 
gastrointestinal resource in the world. 
He is currently chairman of the depart­
ment of internal medicine at Mayo 
Clinic, an equally prestigious division. 
Other concurrent positions at Mayo 
include director for the Center for 
Basic Research in Digestive Diseases, 
distinguished investigator of The 
Mayo Foundation, and consultant in 
gastroenterology and hepatology and 
in biochemistry and molecular biology. 
He has also been professor of medicine 
at Mayo Medical School for 15 years 
and professor of biochemistry and 
molecular biology since 1992.
Dr. LaRusso served as the editor of 
Gastroenterology for five years and is 
currently on the editorial boards of 
other leading journals. His studies in 
gastroenterology have received millions 
of dollars in funding from the National 
Institutes of Health and his research has 
attracted scientists and scholars from 
around the world to his laboratory.
He received the Distinguished Service 
Award from Mayo Medical School, 
Clinic and Foundation; a MERIT Award 
from the National Institutes of Health 
and the Distinguished Achievement 
Award from the New York Medical 
College Alumni Association. He was 
inducted by the College alumni into 
the Alpha Omega Alpha Honor 
Medical Society in 1998.
A member of the President's National 
Advisory Council, Dr. LaRusso 
was featured in recent College 
radio advertisements. ■
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25 Years Later (continued from page 27)
services, we have to break the 
bottleneck of medical manpower," 
College President Dr. Frederick L. 
Stone informed the graduating Class 
of 1970. "Our objective is to 
produce the largest possible number 
of highly qualified professionals in 
the health field—through a Medical 
School with a substantially 
increased enrollment..."
Two years later, the College achieved 
both objectives. By July 1972, the 
four-year medical school curriculum 
had been revised to a three-year 
program and classes were held at 
the College's new campus in 
Valhalla, N.Y. Twenty-six other 
medical schools, including Duke, 
Dartmouth, Albert Einstein and 
Stanford, also instituted three-year 
programs. Some schools, including 
Dartmouth and Stanford, abolished 
all summer vacations and crunched 
the curriculum into 39 months.
Others revised the curriculum, 
eliminated some electives or admitted 
students with advanced standing.
Members of the Class of '75B, 
admitted in June 1972, coped with 
heat, construction and the loneliness 
of being the only class on campus. 
Amy Rosenman, M.D. '75B wrote 
about these experiences in the 1973 
edition of the College newspaper: 
"When we came in June, there was 
one unfinished Basic Sciences 
Building, one medical school class, 
one anatomy department, construc­
tion workers, noise, mud and heat."
Elaine Fox, M.D. '75B remembers the 
Valhalla mud serving as "a perfect 
breeding ground for tadpoles," and 
the difficulty adjusting to the lack 
of housing and transportation on 
campus. The most demanding 
challenge was compensating for 
the abbreviated clinical experiences 
provided during the three-year 
program. "In my internship, 75 
percent of my teammates graduated 
from a four-year program and 90 
percent of those had done sub­
internships that were twice as long as 
my entire elective time," Dr. Fox said. 
"It was absolutely too short a period 
[36 months] to adequately make an 
informed decision or choice of one's 
specialty, one's lifelong career!"
In addition to shortened electives, 
the class was deprived of three 
summer vacations. "It was a terrible 
curriculum," commented Felix 
Wassermann, Ph.D., acting chairman 
of the Department of Microbiology 
and Immunology, who served as 
co-chairman of the Curriculum 
Committee during that period.
"It was too crammed. There wasn't 
enough time for preparation. Do 
you just talk faster? Or are there 
certain areas in the medical school 
curriculum that we don't have to 
teach or don't have to spend as much 
time on? The students were more
New York Medical 
College responded with 
an ambitious initiative— 
the development of 
an academic medical 
center in Westchester 
and launched a 
concerted effort to 
increase the number 
of its graduates.
stressed out," Dr. Wassermann added, 
"and there was a lot of griping among 
faculty about not having enough time 
to present the curriculum."
The Class of '75A, enrolled in the 
four-year program, was undergoing a 
different angst. They had attended 
classes at the New York City campus 
for two years when the College 
moved to Valhalla. "We finished our 
second year and FJetrick Hall, the 
basic science building, was just 
vacated," recalled John McClung, 
M.D. '75A, associate professor of 
medicine and associate director of 
the Cardiovascular Fellowship 
Program at Westchester Medical 
Center. "It was a pretty confusing 
time. If you were in New York City, 
there was always a feeling that things 
were going on in this new place that
you didn't know anything about. We 
were worried about rotations because 
suddenly clinical placements had to 
be found for almost 300 people."
The need for more sites was 
resolved by adding St. Vincent's, 
Lenox Hill and Stamford hospitals 
to Metropolitan and Flower-Fifth 
Avenue hospitals, which were already 
affiliated with the College. Rotations 
decided, the next challenge was 
coordinating the logistics of 
Commencement. Carnegie Hall, the 
traditional graduation site, could not 
accommodate the two classes at one 
ceremony. Relocating graduation to 
the Valhalla campus would facilitate 
a unified ceremony. This suggestion 
was met by "uproar on both sides of 
the aisle," Dr. McClung remembers. 
"Both '75A and '75B vociferously 
protested, 'Graduation has always 
been at Carnegie Hall and we're 
going to graduate from Carnegie 
Hall!"' And they did. Two separate 
Carnegie Hall ceremonies were 
held on June 3, 1975: 10 a.m. for 
the Class of '75A and 2:30 p.m. for 
the Class of '75B.
In the end, sacrificing summer 
vacations, resolving rotations 
and settling the Commencement 
conundrum were short-lived 
dilemmas. In January 1974, the 
Curriculum Committee unanimously 
voted for the College to return to a 
four-year curriculum. Other medical 
schools followed a similar course, 
and by 1979, only 6 percent retained 
the three-year curriculum. "The 
speeded-up programs imposed 
unnecessary emotional, physical and 
economic demands on students.
The intense pace and excessive stress 
of learning concerned both faculty 
and students," noted Robert L. Beran, 
M.D., the former associate director 
of the Association of American 
Medical Colleges.
Nearly 85 percent of the Class of 
'75B survived slogging through 
the mud at the newly constructed 
campus, studying all the time, and 
advocating for meaningful rotations 
to graduate as doctors of medicine. 
"They were the pioneers," Dr. 
McClung maintains, "we were 
the survivors." ■
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Milestones Psychiatrist Advocates For Effective 
Pain Management
The World Health Organization describes palliative care as "the 
total care of the patient whose disease is not responsive to cura­
tive treatment." For Pamela Call, M.D. '83, helping a patient in 
pain "is one of the most important skills I have as a physician."
As chief of Psychosocial Services at the Comprehensive Cancer 
Center and Department of Psychiatry at Saint Vincents Manhattan, 
Dr. Call, a psychiatrist, collaborates with an interdisciplinary 
team of pain management specialists, oncologists, nurses, and 
psychologists who strive to relieve the suffering of people with 
cancer. She realizes her professional commitment from "having 
the opportunity to contribute to the quality of my patients' lives. 
For a patient with a terminal illness, the key issue is the quality 
of each day of life, rather than the quantity of months or years 
that remain," Dr. Call says. "As the physician, I must understand 
and individualize the experiences and needs of every patient 
who is going through a difficult illness. I am very involved with 
my patients. I enjoy a level of Intimacy and intensity with them 
at a critical stage in their lives. It is very satisfying."
1990s
Matthew Hilmi, M.D. '99, is a
maxillofacial surgeon and a 
member of the medical staff of 
Benedictine Hospital in Kingston, 
N.Y. He also holds a doctor of 
medical dentistry degree from 
Fairleigh Dickinson University 
College of Dental Medicine where 
he graduated first in his class.
Maurice Zaccardo, M.P.H. '98,
recently retired after practicing 
dentistry in Tarrytown, N.Y., for 46 
years. Plans to continue working 
in public health.
Kristina Deeter, M.D. '98, is Chief 
Resident of the UTHSC San 
Antonio Pediatrics program. 
Married to Matthew Deter, M.D. 
'98, she writes "Matt is returning 
from a GMO year in Korea and 
will continue his general surgery 
residency at Brooke Army Medical 
Center in San Antonio, Texas."
Mary Grace Pagaduan, M.P.H. '97,
has been appointed assistant direc­
tor of The Community Center in 
Katonah, N.Y. She also volunteers 
at the Bedford Hills Correctional 
Facility in Westchester.
Ben Ha, M.D. '96, has joined a 
group practice in obstetrics and 
gynecology in Terre Haute, Ind.
He completed his residency at the 
State University of New York/ 
Buffalo Children's Hospital.
Thomas H. Rhee, M.D. '96, has
moved from Verona, N.J. His new 
address is 1 Fourteenth Street, Apt. 
1101, Hoboken, N.J. 07030.
Matthew A. Bank, M.D. '95, start­
ed a fellowship in trauma surgery 
and critical care at Yale/New 
Haven University Hospital in July. 
He was formerly chief resident in 
general surgery at Long Island 
Jewish Medical Center.
Susan Pizzuto Campanile, M.D.
'95, is board certified in internal 
medicine and practices in 
Scarsdale, N.Y.
Lawrence J. Fliegelman, M.D. '95,
married Pamela R. Schneider on 
April 8, 2000. He writes "I com­
pleted my residency in otolaryngol- 
ogy/head and neck surgery at The 
Mount Sinai Medical Center in 
New York in June and have begun 
a fellowship in facial plastic and 
reconstructive surgery there."
Kathy Messina, M.D. '95 and 
Thomas Insinna, M.P.H. '95,
proudly announce the birth of their 
second daughter, Natalie Rose on 
May 30. She joins big sister, 
Kaitlyn, who celebrated her third 
birthday in May. Residents of East 
Meadow, N.Y., Kathy practices 
pediatrics on Long Island and Tom 
works for Winthrop South Nassau 
Health System.
Joshua D. Rittenberg, M.D. '95, a
clinical instructor at Northwestern 
University, recently completed a 
spine fellowship at the Florida 
Spine Institute and currently works 
at the Center for Spine and Sports 
at the Rehabilitation Institute 
of Chicago.
Regan Welsh, M.D. '95, made 
history in Redding, Conn.! Her 
son, Ian Davies-Welsh born on 
January 6, was Redding's first baby 
of the new millennium. Mom had 
just completed her residency in 
obstetrics and gynecology at 
Bridgeport Hospital in December. 
Sister, Erin, age 4, and dad, Dr. 
Arthur Davies, an emergency room 
physician, welcome the newest 
member of the family.
Karen M. Buckley, M.D. '94, has
been named assistant director of 
the Burn Center at Westchester 
Medical Center in Valhalla, N.Y. 
She is responsible for supervising 
the care of seriously burned 
patients in the 10-bed unit, treats 
patients in the plastic surgery 
clinic, and supervises a team of 
fellows, residents and medical 
students. Dr. Buckley completed 
her internship and residency in 
general and plastic surgery at 
Cooper Hospital in Camden, N.J. 
"It's good to come back home," 
she said.
James L. Januzzi, M.D. '94, com­
pleted his fellowship in cardiology 
at Massachusetts General Hospital 
and has joined its cardiology staff. 
An instructor in medicine at 
Harvard Medical School, he reports 
"I will continue my research in the 
areas of acute coronary syndromes 
and acute aortic dissection." He 
and his wife, Roberta are expecting 
their second child in October. 
Caterina is 2'" years-old.
Michael A. Sanford, M.D. '94,
completed his residency in urology 
at Mount Sinai Medical Center in 
New York City and moved to Indio 
and Rancho Mirage, Calif., with his 
wife, Lori, and children, Daniel and 
Abigail. His father is Robert S. 
Sanford, M.D. '64.
John Z. Chrabuszcz, M.D. '93,
has joined Catskili Orange 
Orthopaedics in Sullivan County, 
N.Y. Eellowship-trained in foot 
and ankle surgery, he was a 
practicing podiatrist before 
attending medical school.
Mark J. Flynn, M.D. '93, writes 
"my wife and I, along with 
Jonathan, 4, and Stephen, 8 
months, live in Silverdale, Wash.
I am still in the U.S. Navy, and on 
the teaching staff of Puget Sound 
family Medicine, Naval Hospital 
Bremerton, Washington."
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In the 12 years since she corpfilet- 
ed a fellowship In psychiatric 
oncology at Memorial Sloan- 
Kettering Cancer Center, Dr. Call 
has witnessed a gradual shift in 
how patients with acute and 
chronic pain are treated. She is 
encouraged by the "enhanced 
awareness of the need for the 
care I provide. In general, 
patients are undertreated for 
pain." Physicians are concerned 
about side effects of pain medica­
tion. Patients believe that they 
are giving in to the disease if they 
take pain killers. The role of the 
physician is to educate patients 
about the proper use of pain 
medication. We must give them 
permission to feel comfortable."
Pamela Call, M.D. '83
Since joining the staff at Saint Vincents in 1988, she has had a 
variety of jobs that led her to these conclusions. She managed 
the Psychiatric Evaluation Program where she assessed emotional­
ly ill patients who sought treatment either through the emergency 
room or the outpatient clinics. "I saw an extremely heteroge­
neous community of people, patients from Greenwich Village and 
surrounding areas. It was very interesting. Quite colorful," she 
smiled. She has also served as a consultation liaison psychiatrist 
in the general hospital, evaluating trauma patients, individuals on 
the oncology and cardiac units, as well as people with cystic 
fibrosis and AIDS. While treating this varied group of patients, 
she became increasingly aware of a common theme that permeat­
ed her work. "I became concerned with the attitudes and 
practices regarding the management of patients' pain," Dr. Call 
recalled. "There were always concerns about appropriate 
medical treatment for patients, but inadequate concern with 
their comfort and pain management. If the pain is treated, the 
patient's sense of psychological well-being is improved."
In addition to her clinical work. Dr. Call teaches first- and 
third-year College students and lectures second-year residents 
in psychiatry. Her contributions have been recognized by her 
colleagues who, since 1998, have selected her for inclusion in 
the last three editions of New York magazine's "The Best Doctors 
in New York." ■
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Christopher M. Conti, M.D. '92,
Delaware's first Mohs Micrographic 
Surgeon, has joined the staff of 
Panzer Dermatology Associates.
He completed a fellowship in 
Mohs—a reconstructive technique 
that limits the amount of skin 
removed during surgery.
Gene Kennedy, M.D. '92, has
thrown his hat in the ring and is 
running on the Republican ticket 
for coroner in Belmot County,
W.Va. He and his wife Marion 
have lived in Morristown, W.Va. for 
seven years and have a son, age 8, 
and a daughter, age 4.
Karen Pomian Lewison, M.D. '92,
has joined the radiology staff at 
Geisinger Medical Center in 
Danville, Pa., where she resides.
She was formerly a radiologist with 
Pacific Imaging Consultants in 
Oakland, Calif.
Alexander Pushchin, M.D. '92, an
ob/gyn in Syracuse, N.Y., recently 
joined the staff of St. Joseph's 
Maternal Child Health Center.
John P. Swidryk Jr., M.D. '92, has
joined the medical staff of Crockett 
Hospital in Lawrenceburg, Tenn.
He and seven partners comprise 
the Southern Radiology Croup, 
providing radiological and specialty 
services to Crockett and Maury 
Regional hospitals.
Victor J. Weiss, M.D. '92, is
assistant professor of vascular 
surgery and director of the 
Non-Invasive Vascular Laboratory 
at Emory University in Atlanta.
Robert Capodilupo, M.D. '91,
practices cardiology part time 
at Charles A. Dean Memorial 
Hospital and Nursing Home in 
Greenville, Me.
Maurizio Nichele, M.D. '91,
practices surgery in Old Saybrook, 
Conn., and is a life member of 
"Who's Who."
John A. Perrotti, M.D. '91, instructs 
NYMC students at Saint Vincents 
and Metropolitan hospitals and 
practices plastic surgery in 
New York City.
Jeffrey J. Raizer, M.D. '91, a
neuro-oncologist at Memorial 
Sloan-Kettering Cancer Center in 
New York City, was a member of 
the team who cared for the late 
John Cardinal O'Connor, the 
Catholic Archbishop of New York. 
Dr. Raizer completed residencies 
at Yale-New Haven Hospital, New 
York University Medical Center 
and Bellevue Hospital, and was 
a fellow in neuro-oncology 
at Sloan-Kettering.
Richard E. Zambernardi, M.D. '91,
has been appointed to the medical 
staff of Central Maine Medical 
Center in Lewiston. An anesthesi­
ologist, he and his wife, Aileen, 
have two daughters, Christine 
and Caroline.
Elias Chua, M.D. '90, and his
wife, Paula, announce the birth of 
Lauren Michelle. He is practicing 
anesthesiology in Newark, Del. 
"with two other College graduates,
Tak Lin, M.D. '90, and Mark 
Mulvihill, M.D. '88."
Richard J. Ryan, M.D. '90, has
been appointed director of emer­
gency medicine at The Jewish 
Hospital in Cincinnati, Ohio, and 
director of clinical operations. 
Vanguard Medical Inc. An assistant 
professor in the department of 
emergency medicine at the 
University of Cincinnati, he 
and his wife, Melissa, have 
a daughter, Hailey.
1980s
Edward G. Dainesi, M.D. '89,
reports "I'm having a good time 
practicing internal medicine in a 
group practice in McMurray, Pa. 
Busy playing with my two 
daughters, ages 5 and 3.
Golf game improving."
Lawrence J. Green, M.D. '89, is
the author of The Dermatologist's 
Guide To Looking Younger, a 
layperson's guide to the array of 
over-the-counter skin products, 
medical and surgical alternatives 
for treating wrinkles and aging 
skin. An assistant professor of 
dermatology at George Washington 
University School of Medicine in 
Washington, D.C., he practices 
dermatology and dermatologic 
surgery in Rockville, Md.
Victor Sloan, M.D. '89, writes "my 
wife Sandra and i returned from 
China in March where we adopted 
our beautiful daughter, Mei-lin 
Emma Gong Sloan. She has 
brought great joy tp our lives, and 
at 16 months, she has already 
developed a strong personality."
Michael Snyder, M.D. '89, who
practices in Willingboro, N.J., 
reports "I delivered the first Kosovar 
baby born in the United States 
when the refugees came to New 
Jersey in May, 1999. I was inter­
viewed on Good Morning America, 
The Today Show and CNN. An 
article on the delivery appeared on 
the front page of the metro section 
of The New York Times."
Richard P. Bodony, M.D. '88, is
"alive, well and living in Marin 
County, Calif. I am married to 
Michelle Perro, M.D., a former 
attending in pediatrics and 
the emergency room at 
Metropolitan Hospital."
Jeffrey S. Farber, M.D. '88, has
been named medical director of 
Panegyrist Rehabilitation Hospital 
in Delray Beach, Fla.
Cheating Death Through 
Attention To Detail
Edward Briggs, M.P.H. '90
Vigilance, metic­
ulous attention 
to the smallest 




are the attributes 
that guide Ed 
Briggs' work as 
chief sanitarian 
in Ridgefield, a 







to saving his life.
Considered an 
"environmental 
specialist," Briggs, M.P.H. '90, 
assures that federal and state 
public health standards are 
met by the schools, day care 
centers and other public facili­
ties in town. He inspects 
more than 100 restaurants 
quarterly, grants licenses to 12 
swimming pools and manages 
issues ranging from West Nile 
virus and rabid animals to 
controlling communicable 
diseases and halting the 
spread of salmonella poison­
ing. He is also an experi­
enced emergency medical 
service technician trained to 
recognize life-threatening 
conditions. Two years ago, 
he identified his own.
"We had just returned from 
taking a patient who had 
overdosed on drugs to the 
hospital when I started having 
chest pains," Briggs recalled.
"I was sweating profusely, so 
I put myself on the EKC 
machine. The rhythms were 
crazy. I knew 1 was having a 
heart attack. I walked into the 
emergency room at Yale New 
Haven Medical Center and 
told the nurse, 'I'm having a 
heart attack.'"
Briggs, 43, did not have a 
family history of heart disease 
nor had he experienced prior 
symptoms. He underwent a 
quadruple bypass the next 
day and was out of work for 
two months. His cardiologist 
told him that his diagnostic
acumen saved his life. "If I 
hadn't put myself on the 
monitor, I would have died.
It was a serious heart attack," 
he said.
Fully recovered, the chief 
sanitarian for 12 years 
describes his job as "demand­
ing," though not stressful. I'm 
not stuck in a static environ­
ment. One day, I'm testing 
beach samples; then, I may be 
dealing with a case of food 
poisoning or inspecting a new 
septic system. I have to 
respond to questions about 
levels of radon, asbestos or 
lead contamination in housing 
units, the latest test for Lyme 
disease, or the suitability of 
soil for a new septic system. 
But my biggest challenge is 
keeping people happy. No 
matter who you deal with, 
someone isn't going to be 
satisfied," he added.
Briggs, who was named 
"Sanitarian of the Year" by the 
Connecticut Environmental 
Association and the New 
England Region of the 
National Environmental 
Health Association, teaches 
the sanitarian training course 
at Southern Connecticut State 
University. In addition to his 
M.P.H. degree, he holds an 
M.S. in medical laboratory 
sciences from the University 
of Bridgeport. His long-term 
goal is to enroll in a Ph.D. 
program in public health and 
eventually teach part time 
at a university. ■
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David M. Nganele, Ph.D. '87,
has launched Harmony Health 
Communications, a medical educa­
tion company located in Harlem, 
N.Y., that will provide training 
in cultural competency, effective 
communication and other programs 
to physicians and consumers. His 
goals are to "increase the access of 
minority people to health care and 
to educate consumers about health 
care" here and across the country.
Howard B. Kaplan, M.D. '85,
was recently inducted into the 
American College of Physicians, 
American Society of Internal 
Medicine, and practices in 
Darien, Conn.
Francis A. Garofalo, M.D. '84,
practices urology in Norwalk, 
Conn., and is a member of the 
medical staff of Norwalk Hospital 
where he provides laser treatment 
for benign prostatic hyperplasia.
William Varr III, M.D. '84,
specializes in LASIK surgery at 
Kent Ophthalmology in Warwick, 
R.l. Last year he underwent LASIK 
surgery and happily reports he now 
has 20/20 vision.
John M. Feder, M.D. '83, proudly 
announces the birth of Eli Solomon 
on April 18, 2000. He joins older 
brother, Benjamin, age 2®.
Lawrence H. Fein, M.D. '82,
specializes in treating patients 
with sports and dance injuries 
in a recently established practice, 
Orthopedists Associates of 
Saratoga, N.Y., along with two 
other orthopaedic surgeons. He 
and his partners focus on sports 
medicine, and bone and joint 
surgery, with emphasis on 
education and research.
Scott Spector, M.D. '82, of
Westport, Conn., participated in 
"Mission Cataract 2000" providing 
free cataract surgery to 24 patients 
who did not have health insurance. 
He believes he was the only oph­
thalmologist in Connecticut who 
donated his time and the facilities 
of the New Vision and Cataract 
Center to this nationwide program.
Matthew J. Arduino, M.S. '81,
Ph.D., is chief, healthcare 
environment section, diagnostic 
and environmental microbiology 
branch, hospital infections 
program. National Center for 
Infectious Disease at the Centers 
for Disease Control. At the 49“’ 
annual Epidemic Intelligence 
Service conference, held at the 
CDC in April, he received the 
Donald C. Mackel Award for 
Excellence in Epidemiology and 
Laboratory Science and a special 
recognition award for outstanding 
performance from the Food and 
Drug Administration/Center for 
Devices and Radiologic Health.
Record Net of $400,OOO"*' 
Raised at Founder’s Dinner
New York Medical College celebrated Its 140th anniversary in September 
as more than 600 alumni, faculty and friends braved a nor'easter to attend 
the event at the Rye Town Hilton. Besides honoring the memory of founder 
William Cullen Bryant, tribute was paid to three men whose accomplish­
ments were in the best tradition of Mr. By rant. The honorees were, from 
left. Dr. Max Comez, health andsdence editor for "NewsChannel 4," 
who received the first Jackson E. Spears Community Service Award, named 
for the longest running (57 years) College trustee; Trustee George J. Ames, 
general partner and limited managing director of hazard Freres & Co. LLC; 
and Louis R.M. Del Cuercio, M.D., professor and chairman of the 
Department of Surgery. Richard Harbus Photo
Edward Kirby, M.D. '81, recently 
celebrated the first anniversary 
of his practice. Orthopedic 
Specialties of the Hudson Valley, 
in Poughkeepsie, N.Y. He treats 
patients of all ages, specializing 
in injuries and diseases of the 
musculoskeletal system, as well 
as sports and work related injuries. 
He is affiliated with Saint Francis, 
Northern Dutchess and Vassar 
Brothers hospitals.
Brian P. McCann, M.D. '81,
successfully completed his 
recertification and fulfilled the 
requirements of the American 
Board of Emergency Medicine. He 
is affiliated with Franklin Memorial 
Hospital in Greenville, Me.
Anthony J. Aricola, M.D. '80,
sends greetings to all, "especially 
my mates in the class of 1980. I 
have stopped practicing urology 
in Florida and opened my new 
office in Warren, Pa. I missed 
the four seasons and snow, believe 
it or not." His daughter is at the 
Eastman School of Music in 
Rochester, N.Y., and hopes to be 
a conductor. He would like to hear 
from alumni who are practicing in 
the Warren area.
Justin Salerno, M.D. '80, practices 
high-risk obstetrics and gynecology 
in Berwick, Pa.
1970s
Charles B. Slonin, M.D. '78,
reports, "I particularly enjoy 
reconstructive surgery. It feels 
good to improve a patient's eye­
sight and function, as well as 
reducing unsightly scars." An 
associate clinical professor of 
ophthalmology at the University 
of South Florida, he has practiced 
cosmetic and reconstructive surgery 
of the eye at Ophthalmic Plastic 
Surgery Associates in Tampa, Fla., 
for 18 years. "He is world 
renowned for his contact lens 
practice," notes his partner, 
j. Justin Older, M.D.
Michael W. Prystowsky, M.D. '77,
has joined LowCountry's Women's 
Specialists in Charleston, S.C., as 
an associate in obstetrics and gyne­
cology. Formerly in private prac­
tice, he taught at the University 
of Maryland School of Medicine.
Arthur Taubman, M.D. '77, reports 
"I have a large orthopaedic practice 
in Jersey City, N.J."
Joanne Kurtzberg, M.D. '76,
professor of pediatrics and 
associate professor of pathology 
at Duke, is director of the Pediatric 
Bone Marrow Transplant Center 
and director of the Pediatric Bone 
Marrow Laboratory at Duke 
University where she oversees 
research in bone marrow transplan­
tation and the collection, storage 
and transplantation of umbilical 
cord blood.
Stephen Marcus, M.D. '76, is vice 
president, oncology and biotechnol­
ogy at Ivax Corp. in Miami, Fla.
Jane Norton, M.D. '76, is the only 
plastic surgeon in the Coachella 
Valley in California who specializes 
exclusively in cosmetic surgery.
She has discussed laser technology 
and other advances in plastic 
surgery on "The Leesa Gibbons 
Show," "Sally Jesse Raphael" and 
"The Joan Rivers Show" on national 
TV and is frequently quoted in 
articles appearing in Elle, Glamour, 
Allure, Beauty and Marie Claire.
Her practice includes a state and 
nationally accredited outpatient 
surgery center.
Anthony Gray Ellrodt, M.D. '75B,
was appointed chairman of 
medicine and program director 
of internal medicine at Berkshire 
Medical Center in Pittsfield, Mass.
A cardiologist, he was director 
of the division of general internal 
medicine and the internal 
medicine training program, and 
vice chairman of medicine for 
clinical affairs at Cedars-Sinai 
Medical Center in Los Angeles.
He was professor of clinical 
medicine at UCLA, where he 
received the Golden Apple Award 
for outstanding clinical teacher.
Cono M. Grasso, M.D. '74, was
recently elected to the board of 
directors of Maspeth Federal 
Savings in Maspeth, N.Y, his 
home town. He has practiced 
ophthalmology for more than
20 years and is chairman of 
the ophthalmology department of 
the Catholic Medical Center. He 
has developed eye care programs 
for people living in medically 
underserved areas of Brooklyn and 
Queens and has been a member 
of the board of directors of the 
New York State Ophthalmological 
Society and a councilor for 
the American Academy 
of Ophthalmology.
Steven Weinstock, M.D. '74,
writes "I survived gallbladder 
surgery and ERCP pancreatitis this 
year. I'm looking forward to par­
ticipating in the S* consecutive 
two-mile ocean swim competi­
tion." He finished 14th in his age 
group last summer.
Mark L. Fox, M.D. '73, was
recently elected vice speaker to the 
House of Deiegates of the Medical 
Society of the State of New York.
A past president of the Westchester 
County Medical Society, he has 
been a spokesperson for unioniz­
ing physicians. He received the 
"Young at Heart" award from the 
Young Physician Section of the 
Medical Society of the State of 
New York in "appreciation for his 
continued support and encourage­
ment of younger colleagues."
Chief of Otolaryngology-Head and 
Neck Surgery at Lawrence Hospital 
in Bronxville, N.Y., he is immedi­
ate past president of the New York 
State Society of Otolaryngology- 
Head and Neck Surgery.




When Lorah Perlee, Ph.D. '94, was in third grade, shewanted to be a detective. "I always loved solving things.
I loved figuring things out," she said. Childhood ambition 
realized, Lorah Perlee today is a sleuth of sorts. Her investiga­
tions don't entail interrogating suspects in smokey basements 
of police precincts or participating in midnight stake-outs.
Her work is in the laboratory where she supervises the isolation 
and analysis of DNA samples for both clinical use and criminal 
investigations nationwide. With her colleagues at Lifecodes 
Corporation in Stamford, Conn., she has developed newer, faster 
and more accurate technology for DNA analysis that is used 
to classify donor lists for bone marrow and organ transplantation. 
This same technology is used in national databases for identifica­
tion of convicted felons.
Dr. Perlee is director of laboratory operations at Lifecodes where 
she's worked for 13 years. She oversees the clinical laboratory 
operations of the paternity, forensic and transplantation laborato­
ries in Stamford, Nashville, and East Lansing. A resident of 
nearby Wilton, Conn, she started as a forensic scientist, involved 
in isolating and examining DNA samples. "It was very exciting," 
Dr. Perlee recalled. "I would rush into work on Monday, I was so 
excited to find out if a DNA sample had matched. That's when I 
knew I wanted to do this work. It was so much fun."
She also realized that she 
needed a more thorough 
understanding of the 
fundamentals of molecu­
lar biology, enrolled in 
the College's master's pro­
gram and ultimately pur­
sued her doctorate 
in biochemistry and 
molecular biology. Her 
doctoral thesis researched 
the iden^ication and 
sequencing of genes 
in Barrelia burgdorferi, 
which causes Lyme 
disease. "Through my 
thesis research, I learned 
different techniques 
and methodologies for 
manipulating DNA and 
developed a much 
broader understanding 
of the field." Her mentor, 
Ira Schwartz, Ph.D., professor of biochemistry and molecular 
biology, imparted a few life lessons as well. "He generated real 
excitement and enthusiasm for the outcome of experiments,"
Dr. Perlee recalled. "From him I learned that you have to work 
at making sure you do the things you really enjoy."
Within a year of graduation. Dr. Perlee became involved in 
researching and developing a DNA-based testing kit that would 
make it easier to match donor samples for organ and bone 
marrow transplantation. "The HLA field was transitioning 
from using a serological base test and was starting to move 
into molecular base testing. A serological test is not as accurate 
as the DNA test, so our kit hit the market at the perfect time," she 
said. Today, Lifecodes is one of 11 contract labs for the National 
Marrow Donor Program, testing and typing more than 100,000 
donor samples annually. More than 90 percent use the kit 
that Dr. Perlee and the Lifecodes team developed, she said. ■
Lorah Perlee, Ph.D. '94
Marshall Lewis, M.D. '70, has
joined the medical staff at Corcoran 
District Hospital in Corcoran,
Calif., to provide orthopaedic and 
surgical care for people with 
injuries or degenerative diseases of 
the joints and spine. He is a senior 
partner of Pacific Orthopedic 
Medical Group In Bakersfield.
1960s
Theodore E. Eisenstat, M.D. '68,
was recently elected vice president 
of the American Society of Colon 
and Rectal Surgeons and currently 
serves as president of the 
Pennsylvania Society of Colon and 
Rectal Surgeons. A past president 
of the American Board of Colon 
and Rectal Surgery, he was listed in 
New York magazine's "The Best 
Doctors in New York."
Richard Fogler, M.D. '68, was
recently appointed chief medical 
officer at The Brookdale University 
Hospital and Medical Center in 
Brooklyn, N.Y., and remains as 
chairman of surgical services. A 
clinical associate professor of 
surgery at SUNY Health Science 
Center, he has been chairman of 
Brookdale's Cancer Committee 
and director of its tumor board 
for 21 years.
Martin J. Bertman, M.D. '65,
is fully retired and lives in 
Golden Beach, Fla. "My four 
daughters are married and I have 
five grandchildren."
Albert Pineda, M.D. '63, a former 
clinical instructor in obstetrics and 
gynecology at NYMC and attending 
physician at Metropolitan Hospital, 
was honored in May by the 
Passaic, N.J., chapter of the 
American Cancer Society for his 
"dedication to community service 
and commitment to the fight 
against cancer." A specialist in 
gynecological oncology, he was 
executive committee chairman and 
member of the board of managers 
of the American Cancer Society 
and chairman of the Neoplastic 
Committee of Passaic County. He 
also has been a board member of 
the Passaic County Medical Society 
and St. Joseph's Hospital and 
Medical Center.
Howard Jewell, M.D. '62, writes 
"I have been happily retired for 
10 years. Marian and I travel a lot, 
including cruising with our family 
to celebrate our 50th wedding 
anniversary." A resident of Ocean, 
N.J., he would like to hear from 
classmates through e-mail 
(haywell@juno.com).
Neil A. Kurtzman, M.D. '61, was
awarded the Telesio Gold Medal 
at the Second International 
Conference on Edema held in 
Cosenza, Italy, in May, for his 
"outstanding contribution to 
nephrology." He is university 
distinguished professor, Arnett 
Professor of Medicine and professor 
of physiology in the department of 
internal medicine at the School of 
Medicine, Texas Tech University 
Health Sciences Center in 
Lubbock, Texas.
Robert Fabricant, M.D. '60, lives 
in Bricktown, N.J. "After more 
than 500 deliveries, I will retire 
from obstetrics and continue 
with gynecology."
Ronald H. Hartman, M.D. '60,
practices ophthalmology in 
Lakewood and Los Alamitos, Calif., 
is chairman of the governing board 
at Lakewood Regional Medical 
Center and is clinical professor of 
ophthalmology at the University of 
California at Irvine Medical School. 
"Fortunately, my family is well," he 
writes. "I have four boys who are 
all successful and married and I am 
blessed with seven grandchildren.
I would like to report on another 
blessing that I enjoy. My son, Carl, 
has become my partner in the 
practice of ophthalmology."
Eugene Sweeney, M.D. '60, was
promoted to associate clinical 
professor of dermatology at the 
College of Physicians and Surgeons 
of Columbia University, and 
associate attending in dermatology 
at the New York Presbyterian 
Hospital. "I am still in practice 
and enjoyed the alumni luncheon."
1950s
Roland K. Molinet, M.D. '59, lives 
in Fort Lauderdale, Fla., and reports 
that his daughter Arielle graduated 
from high school with honors. She 
is currently enrolled in the honors 
program at Tulane University.
Walter Uhlman, M.D. '59, has
been the medical examiner in 
Hunterdon County, N.J., for 17 
years. He attributes his career 
choice to a serendipitous event 
that occurred during his residency. 
"One day I was asked to help 
perform autopsies and it sort of 
stuck with me." The widower 
enjoys hunting and skiing with his 
two sons and has no immediate 
plans to retire. "What other job 
can you do that is intellectually 
challenging and will always 
be interesting?"
36
James M. Gibbons Jr., M.D. '58, a
widower for two years, retired in 
April from an orthopaedic pratice 
at Mount Auburn Hospital in 
Cambridge, Mass., where he was 
also a faculty member at Harvard 
Medical School, "I was very 
successful in practice," he writes.
"I served on the Board Registration 
of Medicine and was past president 
of the New England Orthopedic 
Society. Thank You New York 
Medical College!"
William E. Mattey, M.D. '58,
has practiced radiology for 36 
years with the Saint Barnabas 
Health Care System in New Jersey. 
He served as chairman of the 
department of radiology at 
Community Medical Center in 
Toms River for 23 years, and enjoys 
winter radiology ski conferences 
and European travel. "No plans 
to retire."
Joseph F. Fennelly, M.D. '56,
received the Edward J. Ill Award 
from the Academy of Medicine 
of New Jersey in recognition of 
his "tireless involvement with 
political and other influential 
leaders on behalf of the medical 
ethics community." An attending 
physician in the department of 
medicine at Morristown Memorial 
Hospital, he is immediate past 
chairman and served on the 
BioEthics Committee of the Medical 
Society of New Jersey and the New 
Jersey Bioethics Commission. He 
also wrote the New Jersey "living 
will" statute and has contributed to 
the medical society's Supreme 
Court argument against physician- 
assisted suicide. He has held 
teaching appointments at Rutgers 
Medical School, New York Medical 
College and Columbia University.
John Davis, M.D. '55, is part-time 
medical director at ViaHealth of 
Wayne, N.J. He served as presi­
dent of the regional chapters of 
both the American Heart and 
American Lung associations and is 
former state president of the latter. 
He and his wife, Martha, a third 
grade teacher in Newark, run an 
antique and collectible business 
through a co-op called "Alan's 
Antique Alley." They have 
seven grandchildren.
James J. Finnerty, M.D. '55, of
Charlottesville, Va., returned to the 
College for a happy occasion. His 
son Emmet, a member of the Class 
of 2000, was awarded a Master of 
Science in Clinical Research 
Administration.
Paul Tucci, M.D. '51, clinical 
professor of urology, was elected 
to the boards of New York College 
of Podiatric Medicine and the Foot 
Clinics of New York, the clinical 
component of the college. He 
lives in Rye, N.Y., and is active 
in a number of professional and 
educational programs.
John J. Vagell, M.D. '51, is
enjoying retirement. "I am looking 
forward to our 50th class reunion 
next year. Best wishes to all 
my classmates."
Rudolph D. Shoucair, M.D. '50,
writes, "I enjoyed the 50th Class 
Reunion festivities which were well 
planned and went off beautifully. 
Since my return, I was honored by 
the Medical Association of Jamaica 
for outstanding medical service to 
the country."
Ralph E. Snyder, M.D. '50, was
recently honored by the Medical 
Review of North Carolina, Inc., 
with an annual quality conference 
in his name: "Ralph E. Snyder,
M. D. Conference on Improving 
Health Care in North Carolina."
A resident of Whispering Pines,
N. C., Dr. Snyder has given 15 
years of "distinguished service to 
improving quality health care for 
Medicare beneficiaries."
1940s
Laura Grey Morgan, M.D. '49,
reports she is enjoying every 
moment of full retirement. She 
spends her leisure time tending 
her window box garden on her 
balcony in Old Greenwich, Conn.
"I had to give up my large garden 
because I couldn't compete 
with the deer, rabbits and other 
varmints!" She has fond 
memories of NYMC and especially 
remembers Dr. Evans' reassuring 
words to the anatomy class: "Don't 
worry, you'll all be Sophomores!"
Stephen Fromer, M.D. '44, is
currently working on a book on life 
during and after medical school 
that will contain "a few hundred 
pictures, cartoons and incidents."
Harold M. Gordon, M.D. '43, is
retired and enjoying life in Santa 
Cruz, Calif. "I have an ocean 
view and enjoy Monterey Bay 
and the pleasant weather." He 
continues to earn CME credits at 
the local hospital.
John L. Tyler, M.D. '43, retired in 
1983 after directing the emergency 
room at Dover General Hospital 
in Dover, N.J., for 14 years. He 
served as a medical officer at the 
Signal Corps Station in Asmara, 
Eritrea, from 1944 to 1947, and 
was discharged from the Major 
Medical Corps in 1947.
1930s
In Memoriam
Irwin H. Ardam, M.D. '54, died April 28, 2000.
Leopold Beliak, M.D. '44, died March 24, 2000, in Mamaroneck, N.Y.
Arnold Bernstein, M.D. '69, died February 10, 2000, in Atlanta, Ca.
Letizia C. Ciaramelli, M.D. '42, died May 23, 2000, in Moorpark, Calif. 
Dominick H. Cerritelli, Jr., M.D. '62, died February 23, 2000, 
in New Haven, Conn.
Catherine Dalton, M.D. '48, died June 9, 2000.
Anne E. Dyson, M.D. '77, died September 21, 2000 in Millbrook, N.Y.
John F. Egan, M.D. '49, died February 29, 2000, in Portland, Me.
Ralph Emerson Hurst, M.D., '49, died February 8, 2000, in Winter Park, Fla. 
Viola Fleischmann, M.D. '36, died June 20, 2000, in South Orange, N.J.
Thomas L. Ippolito, Sr., M.D. '36, died September 6, 2000, in Norwalk, Conn. 
Mavis Kaufman, M.D. '44, died March 21, 2000.
Edward J. Kelly, M.D. '44, died July .23, 2000 in Scranton, Penn.
William A. Leibler, M.D. '56, died June 19, 2000, in New York, N.Y.
Thomas F.X. Lenihan, M.D. '44, died July 11, 2000, in Mahwah, N.J.
Craig Andrew Lipkin, M.D. '96, died May 6, 2000.
Elias Livingston, M.D. '37, died July 19, 2000, in Morristown, N.J.
Robert D. Mackenzie, M.D. '79, died October 29, 1999.
Edward J. McDermott, M.D. '42, died July 29, 2000 in the Bronx, N.Y.
E. Edward Napp, M.D. '33, died March 15, 2000, in Northfield, Vt.
Anthony Noto, M.D. '37, died Mardt 28, 2000, in Falls Church, Va.
Dele Olujobi, M.D. '85, died May 28, 2000, in Canandaigua, N.Y.
Ralph J. Ragosta, M.D. '39, died April 22, 2000, in Springfield, Va.
Joseph Bernard Shapse, M.D. '42, died September 28, 2000, in Morristown, N.J. 
Thomas V. Stack, Jr., M.D. '47, died February 13, 2000.
Stanley H. Warmund, M.D. '49, died April 17, 2000, in Delray Beach, Fla.
Ezra A. Wolff, M.D. '30, died on February 2, 1999.
Faculty
Charles E. Ford, Ed.D., died May 23, 2000, in Bridgeport, Conn.
Calendar of Events
January 19 and 20, 2001
Los Angeles Area Alumni Receptions
January 28-February 2, 2001
Winter CME Seminar
Hyatt Regency Cerromar Beach Resort
Dorado, Puerto Rico
May 5-6, 2001 
Reunion Weekend 2001
May 5 Alumni Banquet and Awards Presentation 
Class of 1951 Awarding of Gold Diplomas 
Class of 1976 Awarding of Silver Diplomas 
The Plaza Hotel 
New York, New York
May 6 Fifth-year Class Reunions
Luncheon and Campus Tours 
Alumni Center 
Valhalla, New York
Honorary Classes: 1936, 1941, 1946, 1951, 
1956, 1961, 1966, 1971, 1976, 1981, 1986, 
1991, and 1996
Malcolm C. Colmer, M.D. '38,
reports, "I'm still around and kick­
ing despite cervical cord pressure 
which required open resection of 
vertebral bodies, bone graft and 
titanium plate to stabilize." He 
wonders if there are "any '38s in 
southwest Forida?"
For additional information, please call the 
Alumni Office at (914) 594-4556.
We're on the Web...
Visit us at http://www.nvmc.edu/alumni/ and tell us about yourself. 
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